SDHA encodes the flavoprotein (Fp) subunit of succinate dehydrogenase (SDH, Complex II), a heterotetrameric enzyme (SDHA/SDHB/SDHC/SDHD) embedded in the mitochondrial inner membrane. SDHA contains a covalently bound FAD cofactor (attached at His99) and catalyzes the oxidation of succinate to fumarate as part of the TCA cycle. The electrons from succinate oxidation are transferred via FAD to the iron-sulfur clusters in SDHB and ultimately to ubiquinone bound at the SDHC/SDHD membrane interface, coupling the TCA cycle to the electron transport chain. Complex II is unique among OXPHOS complexes in that it does NOT pump protons across the inner membrane. SDHA also functions as a tumor suppressor; loss-of-function mutations cause paraganglioma/pheochromocytoma (PPGL5) via succinate accumulation and pseudohypoxic HIF1a stabilization. Biallelic mutations cause Leigh syndrome, mitochondrial complex II deficiency, and dilated cardiomyopathy.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0008177
succinate dehydrogenase (quinone) activity
|
IBA
GO_REF:0000033 |
MODIFY |
Summary: IBA annotation for the overall SDH quinone reductase activity. GO:0008177 is defined as "the overall reaction of the entire SDH complex" (succinate + quinone -> fumarate + quinol). The IBA uses the qualifier 'enables' which is debatable for a single subunit of a complex enzyme. However, SDHA alone can catalyze the succinate -> fumarate half-reaction (the succinate dehydrogenase activity per se), and it is the catalytic subunit where the substrate binding and FAD-mediated oxidation occurs. The full quinone reduction requires all four subunits. The IMP annotation from PMID:7550341 uses 'contributes_to' which is arguably more precise for the full quinone-dependent reaction. Nevertheless, IBA annotations are well-curated phylogenetic inferences and the 'enables' qualifier is defensible since SDHA provides the primary catalytic function of the complex. The deep research review (SDHA-deep-research-falcon.md) confirms that the FAD cofactor is covalently linked in the SDHA subunit via a conserved histidine, essential for catalysis in characterized complex II enzymes.
Reason: SDHA is the catalytic subunit of SDH complex containing the FAD cofactor and active site for succinate oxidation. While the full quinone reduction requires the entire complex, SDHA's role is central and catalytic. The IBA is phylogenetically sound, but the enables qualifier should not be accepted as-is for the whole-complex quinone reaction. Use an intrinsic succinate dehydrogenase activity term for SDHA's enabled activity and retain GO:0008177 only with contributes_to.
Proposed replacements:
succinate dehydrogenase activity
Supporting Evidence:
PMID:37098072
The active site for succinate-fumarate interconversion is located at the interface between the FAD-binding domain and the capping domain
PMID:7550341
We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit gene of the succinate dehydrogenase (SDH) in two siblings with complex II deficiency
file:human/SDHA/SDHA-deep-research-falcon.md
Complex II (succinate dehydrogenase, SDH) catalyzes the oxidation of succinate to fumarate, coupling two-electron transfer via FAD and iron-sulfur centers to reduce ubiquinone to ubiquinol in the inner mitochondrial membrane
|
|
GO:0045273
respiratory chain complex II (succinate dehydrogenase)
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation that SDHA is part of respiratory chain complex II. This is a core structural annotation for SDHA as the flavoprotein subunit of the SDH/Complex II heterotetramer (SDHA+SDHB+SDHC+SDHD). Confirmed by cryo-EM structure (PMID:37098072).
Reason: SDHA is unambiguously a subunit of Complex II. The cryo-EM structure at 2.86A shows all four subunits including SDHA in the complex (PMID:37098072). This is a core annotation.
Supporting Evidence:
PMID:37098072
All the four subunits (SDHA, SDHB, SDHC, and SDHD) were detected by SDS-PAGE (SI Appendix, Fig. S1D) and mass spectrometry (MS) (SI Appendix, Table S1).
|
|
GO:0050660
flavin adenine dinucleotide binding
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for FAD binding. SDHA contains a covalently bound FAD cofactor attached at His99 (Tele-8alpha-FAD histidine). This is confirmed by crystal and cryo-EM structures (PMID:32887801, PMID:37098072). Note that GO:0071949 (FAD binding) is also annotated via Reactome. GO:0050660 is the more general term. Both are appropriate; this IBA is correct.
Reason: FAD binding is a core molecular function of SDHA. The FAD cofactor is covalently attached to His99 and is essential for catalysis. Supported by multiple structural studies.
Supporting Evidence:
PMID:37098072
The hydrophilic head of human CII consists of the flavin adenine dinucleotide (FAD)-binding protein (SDHA)
PMID:19628817
Sdh5 is required for SDH-dependent respiration and for Sdh1 flavination (incorporation of the flavin adenine dinucleotide cofactor)
|
|
GO:0006121
mitochondrial electron transport, succinate to ubiquinone
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for the specific biological process of electron transport from succinate to ubiquinone. This is the defining biological process for Complex II/SDH in the mitochondrial electron transport chain. SDHA initiates this process by oxidizing succinate via FAD and passing electrons through the iron-sulfur centers of SDHB to ubiquinone at SDHC/SDHD.
Reason: This is a core biological process annotation for SDHA. The electron flow from succinate to ubiquinone begins at SDHA's FAD cofactor. This is the defining ETC function of Complex II.
Supporting Evidence:
PMID:37098072
we propose that the human CII succinate- and ubiquinone-binding sites are likely to be connected by a similar chain of redox centers
|
|
GO:0009055
electron transfer activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for electron transfer activity. SDHA is the initial electron acceptor in Complex II, receiving electrons from succinate via its FAD cofactor. The electrons then transfer through the [2Fe-2S] cluster of SDHB. This is a core molecular function annotation.
Reason: SDHA performs electron transfer as part of the succinate-to-ubiquinone chain. The FAD cofactor accepts electrons from succinate and transfers them to the iron-sulfur protein SDHB. This is phylogenetically and biochemically well-supported.
Supporting Evidence:
PMID:37098072
The edge-to-edge distance between these redox-active prosthetic groups is less than 14 Ă
(Fig. 3), a distance range that can efficiently support the delivery of electrons between these redox centers (22)
|
|
GO:0005743
mitochondrial inner membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: IEA annotation based on UniProt subcellular location mapping. SDHA is a peripheral membrane protein on the matrix side of the inner mitochondrial membrane, as part of Complex II. Confirmed by cryo-EM (PMID:37098072) and UniProt subcellular location annotation.
Reason: Correct localization. SDHA is the matrix-facing subunit of Complex II which is anchored in the inner mitochondrial membrane via SDHC and SDHD. The IEA mapping is accurate and consistent with experimental data including the cryo-EM structure.
Supporting Evidence:
PMID:37098072
The entire hydrophobic domain contains two membrane-anchored subunits: SDHC and SDHD
|
|
GO:0006099
tricarboxylic acid cycle
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for TCA cycle involvement. SDHA catalyzes step 6 of the TCA cycle: the oxidation of succinate to fumarate. This is one of the two core biological processes of Complex II (the other being ETC).
Reason: TCA cycle involvement is a core function of SDHA. The succinate to fumarate reaction is a canonical step of the TCA cycle. Widely supported by literature.
Supporting Evidence:
PMID:37098072
Human complex II is a key protein complex that links two essential energy-producing processes: the tricarboxylic acid cycle and oxidative phosphorylation
|
|
GO:0008177
succinate dehydrogenase (quinone) activity
|
IEA
GO_REF:0000120 |
MODIFY |
Summary: IEA annotation for the same SDH quinone activity as the IBA above, inferred from combined automated methods (UniProt keyword, InterPro, EC number). Redundant with the IBA and IMP annotations but consistent.
Reason: Consistent with Complex II function, but not acceptable as an enables annotation for SDHA alone. The quinone-dependent reaction is performed by the intact heterotetramer; SDHA's enabled activity is the succinate dehydrogenase half-reaction.
Proposed replacements:
succinate dehydrogenase activity
|
|
GO:0016491
oxidoreductase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for general oxidoreductase activity. SDHA catalyzes the oxidation of succinate (EC 1.3.5.1), making it an oxidoreductase. This is a correct but very broad parent term. The more specific child terms (GO:0008177, GO:0016627) are also annotated.
Reason: Correct but general. It is acceptable for IEA annotations to be broader than experimental annotations. The more specific GO:0008177 is also present.
|
|
GO:0016627
oxidoreductase activity, acting on the CH-CH group of donors
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: IEA annotation from InterPro mapping. SDHA oxidizes succinate to fumarate, converting a CH-CH single bond to a C=C double bond. This is an accurate intermediate-level classification of the catalytic activity.
Reason: Correct classification. Succinate oxidation to fumarate involves removal of two hydrogens from the CH2-CH2 group to form the trans double bond of fumarate. This InterPro-based IEA is accurate.
|
|
GO:0022900
electron transport chain
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: IEA annotation for general electron transport chain involvement from InterPro. This is broader than GO:0006121 (mitochondrial electron transport, succinate to ubiquinone) which is the more specific IBA annotation. Both are correct.
Reason: Correct but more general than the IBA annotation GO:0006121. Complex II is part of the electron transport chain. Acceptable for IEA to use the broader term.
|
|
GO:0050660
flavin adenine dinucleotide binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: IEA annotation for FAD binding from InterPro. Redundant with the IBA annotation for the same term. Both are correct.
Reason: Correct and consistent with the IBA annotation. FAD is covalently bound to SDHA at His99.
|
|
GO:0005515
protein binding
|
IPI
PMID:17353931 Large-scale mapping of human protein-protein interactions by... |
KEEP AS NON CORE |
Summary: IPI annotation from large-scale mass spectrometry protein-protein interaction study (Ewing et al. 2007). The WITH/FROM field indicates interaction with HLA-B (P01889). This is from a high-throughput screen and the biological significance of an SDHA-HLA-B interaction is unclear. Likely a non-specific or indirect detection.
Reason: High-throughput protein-protein interaction data. The SDHA-HLA-B interaction has no known biological relevance and is likely an artifact of overexpression-based mass spectrometry. Furthermore, 'protein binding' is uninformative as a GO term. Keep as non-core.
|
|
GO:0005515
protein binding
|
IPI
PMID:19628817 SDH5, a gene required for flavination of succinate dehydroge... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction between SDHA and SDHAF2/SDH5 (Q9NX18). Hao et al. (2009) showed that SDH5/SDHAF2 is required for flavination of succinate dehydrogenase. The interaction between SDHA and SDHAF2 is essential for covalent FAD attachment. This is a biologically meaningful interaction confirmed by UniProt (INTERACTION section) and multiple studies.
Reason: The SDHA-SDHAF2 interaction is biologically meaningful (required for FAD cofactor insertion), but 'protein binding' is too vague. The interaction is better captured by the functional context (SDHAF2 is a complex II assembly factor). Keep as non-core since the underlying biology is valid even though the GO term is uninformative.
Supporting Evidence:
PMID:19628817
Both yeast and human Sdh5 interact with the catalytic subunit of the succinate dehydrogenase (SDH) complex ... Sdh5 is required for SDH-dependent respiration and for Sdh1 flavination
|
|
GO:0005515
protein binding
|
IPI
PMID:19688755 LC-MS/MS as an alternative for SDS-PAGE in blue native analy... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with SDHB (P21912) from LC-MS/MS analysis of blue native PAGE-separated complexes. This confirms the well-established SDHA-SDHB interaction as part of Complex II assembly.
Reason: The SDHA-SDHB interaction is a core biochemical feature of Complex II, but this is already captured by the CC annotation GO:0045273 (part_of respiratory chain complex II). The 'protein binding' annotation is uninformative. Keep as non-core.
|
|
GO:0005515
protein binding
|
IPI
PMID:24606901 Cochaperone binding to LYR motifs confers specificity of iro... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with SDHB (P21912) from a study on cochaperone binding to LYR motifs for iron-sulfur cluster delivery. This relates to Complex II assembly.
Reason: Another SDHA-SDHB interaction detected in the context of iron-sulfur cluster delivery. Biologically relevant to Complex II assembly but 'protein binding' is uninformative.
|
|
GO:0005515
protein binding
|
IPI
PMID:26496610 A human interactome in three quantitative dimensions organiz... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with SDHAF2 (Q9NX18) from a quantitative interactome study (Hein et al. 2015). Confirms the SDHA-SDHAF2 assembly factor interaction.
Reason: Confirms the SDHA-SDHAF2 interaction in an independent quantitative study. Biologically relevant but 'protein binding' remains uninformative as a GO term.
|
|
GO:0005515
protein binding
|
IPI
PMID:26618866 âF508 CFTR interactome remodelling promotes rescue of cystic... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with CFTR (P13569) from a study on deltaF508-CFTR interactome remodelling. The biological significance of SDHA-CFTR interaction is questionable -- this is likely a non-specific detection in a large-scale study.
Reason: The SDHA-CFTR interaction is of unclear biological significance. CFTR is an ABC transporter involved in chloride conductance, and its interaction with a mitochondrial enzyme is likely indirect or an artifact. Keep as non-core.
|
|
GO:0005515
protein binding
|
IPI
PMID:26749241 Disease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clu... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with SDHB (P21912) from a study on SDHAF1 mutations impairing Fe-S cluster transfer to SDHB. Relevant to Complex II assembly.
Reason: SDHA-SDHB interaction confirmed in the context of Fe-S cluster assembly. Biologically meaningful but 'protein binding' is uninformative. Already captured by CC annotation.
|
|
GO:0005515
protein binding
|
IPI
PMID:28330616 Systematic Analysis of Human Protein Phosphatase Interaction... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with PTPN3 (P26045) from systematic analysis of human protein phosphatase interactions. The biological relevance of an SDHA-PTPN3 interaction is unclear. PTPN3 is a tyrosine phosphatase. SDHA is known to be phosphorylated at Tyr-215 by SRC, so a phosphatase interaction could be biologically relevant but is not well characterized.
Reason: High-throughput phosphatase interaction study. While SDHA is phosphorylated at Y215, the specific relevance of PTPN3 interaction is not established.
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with SDHB (P21912) from architecture of the human interactome study (Huttlin et al. 2017). Confirms SDHA-SDHB subunit interaction.
Reason: Another confirmation of the SDHA-SDHB interaction. Already well established and captured by the CC annotation for Complex II membership.
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with SDHAF2 (Q9NX18) from the same architecture of the human interactome study (Huttlin et al. 2017). This is the second GOA entry for this PMID, detecting the SDHA-SDHAF2 assembly factor interaction.
Reason: Confirms the SDHA-SDHAF2 interaction. SDHAF2 is the assembly factor required for FAD insertion into SDHA. Biologically meaningful but 'protein binding' is uninformative.
|
|
GO:0005515
protein binding
|
IPI
PMID:29128334 A Map of Human Mitochondrial Protein Interactions Linked to ... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with HLA-B (P01889) from mitochondrial protein interaction map linked to neurodegeneration. Same interactor as PMID:17353931. The biological significance of SDHA-HLA-B interaction remains unclear.
Reason: Second independent detection of SDHA-HLA-B interaction, but the biological relevance remains unclear. HLA-B is an MHC class I molecule, not expected to functionally interact with a mitochondrial matrix enzyme.
|
|
GO:0005515
protein binding
|
IPI
PMID:29924966 A Proteomic Variant Approach (ProVarA) for Personalized Medi... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with CFTR (P13569) from a proteomic variant approach study. Second SDHA-CFTR interaction, of unclear biological significance.
Reason: SDHA-CFTR interaction detected by proteomics. Unclear biological significance.
|
|
GO:0005515
protein binding
|
IPI
PMID:31324722 Inhibition of calpain 1 restores plasma membrane stability t... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with CFTR (P13569) from study on calpain 1 and Phe508del-CFTR. Third SDHA-CFTR interaction detection. Multiple detections suggest a real physical interaction but its functional significance for SDHA is unclear.
Reason: Third detection of SDHA-CFTR interaction. While multiple detections suggest a real interaction, the functional significance for SDHA function is unclear.
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with SDHB (P21912) from dual proteome-scale network study (Huttlin et al. 2021). Confirms the known Complex II SDHA-SDHB subunit interaction.
Reason: Confirms the SDHA-SDHB interaction. Well established and captured by CC annotation.
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with SDHAF2 (Q9NX18) from dual proteome-scale network study (Huttlin et al. 2021). This is the second GOA entry for this PMID, confirming the SDHA-SDHAF2 assembly factor interaction.
Reason: Confirms the SDHA-SDHAF2 interaction. Well established.
|
|
GO:0005515
protein binding
|
IPI
PMID:35156780 CFTR interactome mapping using the mammalian membrane two-hy... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with CFTR (P13569) from membrane two-hybrid screening. Fourth SDHA-CFTR interaction detection.
Reason: Yet another SDHA-CFTR detection. While robust, CFTR interaction is not relevant to the core function of SDHA.
|
|
GO:0005739
mitochondrion
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation for mitochondrial localization via Ensembl Compara ortholog transfer. SDHA has a mitochondrial transit peptide (residues 1-42) and is localized to the mitochondrial matrix as part of Complex II.
Reason: Correct localization, well supported by multiple lines of evidence including the transit peptide and IDA evidence.
|
|
GO:0005759
mitochondrial matrix
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation for mitochondrial matrix localization via Ensembl Compara ortholog transfer. SDHA faces the matrix side of the inner membrane as a peripheral membrane protein.
Reason: Correct. SDHA is on the matrix side of the inner mitochondrial membrane, confirmed by cryo-EM structure (PMID:37098072) showing SDHA in the hydrophilic head of Complex II facing the matrix.
Supporting Evidence:
PMID:37098072
The hydrophilic head of human CII consists of the flavin adenine dinucleotide (FAD)-binding protein (SDHA) and the iron-sulfur protein (SDHB)
|
|
GO:0045273
respiratory chain complex II (succinate dehydrogenase)
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation for Complex II membership via Ensembl Compara ortholog transfer. Redundant with IBA and other annotations for the same term.
Reason: Correct and consistent with IBA, ISS, IDA, and TAS annotations for this term.
|
|
GO:0005739
mitochondrion
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: IDA annotation for mitochondrial localization from HPA immunofluorescence data. Direct experimental evidence of SDHA mitochondrial localization.
Reason: Direct experimental evidence of mitochondrial localization by immunofluorescence.
|
|
GO:0006099
tricarboxylic acid cycle
|
TAS
Reactome:R-HSA-71403 |
ACCEPT |
Summary: TAS annotation from Reactome TCA cycle pathway. SDHA participates in the TCA cycle by catalyzing the succinate to fumarate step.
Reason: Core function annotation. Consistent with IEA and NAS annotations for the same term. SDHA is a canonical TCA cycle enzyme.
|
|
GO:0005743
mitochondrial inner membrane
|
NAS
PMID:30030361 Assembly of mammalian oxidative phosphorylation complexes I-... |
ACCEPT |
Summary: NAS annotation from ComplexPortal based on review by Signes and Fernandez-Vizarra (2018) on assembly of OXPHOS complexes. SDHA is part of Complex II which is embedded in the inner mitochondrial membrane.
Reason: Correct localization. Complex II spans the inner membrane via SDHC/SDHD subunits, with SDHA on the matrix side as a peripheral membrane protein.
|
|
GO:0006099
tricarboxylic acid cycle
|
NAS
PMID:30030361 Assembly of mammalian oxidative phosphorylation complexes I-... |
ACCEPT |
Summary: NAS annotation from ComplexPortal for TCA cycle involvement. Redundant with other TCA cycle annotations but consistent.
Reason: Correct and consistent with other TCA cycle annotations from Reactome and IEA sources.
|
|
GO:0006121
mitochondrial electron transport, succinate to ubiquinone
|
NAS
PMID:30030361 Assembly of mammalian oxidative phosphorylation complexes I-... |
ACCEPT |
Summary: NAS annotation from ComplexPortal for the specific ETC process. Consistent with the IBA annotation for the same term.
Reason: Correct. This is a core biological process for SDHA/Complex II.
|
|
GO:0042776
proton motive force-driven mitochondrial ATP synthesis
|
NAS
PMID:30030361 Assembly of mammalian oxidative phosphorylation complexes I-... |
REMOVE |
Summary: NAS annotation from ComplexPortal suggesting SDHA is involved in proton motive force-driven mitochondrial ATP synthesis. This annotation is problematic because Complex II does NOT pump protons across the inner mitochondrial membrane. Unlike Complexes I, III, and IV which translocate protons to generate the proton motive force, Complex II transfers electrons from succinate to ubiquinone without any proton pumping. Complex II contributes to ATP synthesis only indirectly by feeding reduced ubiquinol into the Q pool, which is then oxidized by Complex III (which does pump protons). Annotating SDHA with this term conflates electron donation to the Q pool with proton translocation.
Reason: Complex II is the only OXPHOS complex that does NOT pump protons. The proton motive force is generated by Complexes I, III, and IV. Complex II feeds electrons into the ubiquinone pool but does not directly contribute to the proton gradient. This annotation is misleading and should be removed. The correct process annotation for SDHA is GO:0006121 (mitochondrial electron transport, succinate to ubiquinone).
Supporting Evidence:
PMID:37098072
The respiratory chain (also called electron transport chain) consists of complexes I-IV. It oxidizes the reducing equivalents in nicotinamide adenine dinucleotide (NADH) and succinate using molecular oxygen and couples the translocation of protons from the mitochondrial matrix into the intermembrane space
|
|
GO:0071949
FAD binding
|
TAS
Reactome:R-HSA-9854672 |
ACCEPT |
Summary: TAS annotation from Reactome for FAD binding. The Reactome entry R-HSA-9854672 describes the covalent attachment of FAD to SDHA. GO:0071949 (FAD binding) specifically refers to binding the oxidized form of FAD, which is appropriate for SDHA.
Reason: Correct. SDHA covalently binds FAD at His99. This is the more specific FAD binding term compared to GO:0050660, and both are appropriate. Reactome accurately captures this step of Complex II maturation.
|
|
GO:0005739
mitochondrion
|
HTP
PMID:34800366 Quantitative high-confidence human mitochondrial proteome an... |
ACCEPT |
Summary: HTP annotation for mitochondrial localization from a quantitative high-confidence human mitochondrial proteome study (Morgenstern et al. 2021). SDHA was identified in the mitochondrial proteome.
Reason: Correct. SDHA is a well-established mitochondrial protein confirmed by proteomics.
|
|
GO:0045273
respiratory chain complex II (succinate dehydrogenase)
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation for Complex II membership by manual transfer from bovine ortholog (Q0QF01). Consistent with all other annotations for this term.
Reason: Correct. Transfer from the well-characterized bovine SDH complex.
|
|
GO:0008177
succinate dehydrogenase (quinone) activity
|
IMP
PMID:7550341 Mutation of a nuclear succinate dehydrogenase gene results i... |
ACCEPT |
Summary: IMP annotation with 'contributes_to' qualifier from the landmark Bourgeron et al. (1995) study. This study identified the first nuclear gene mutation causing mitochondrial respiratory chain deficiency -- an Arg554Trp mutation in SDHA causing Leigh syndrome with complex II deficiency. The 'contributes_to' qualifier is appropriate for GO:0008177 since the GO term definition states "This term represents the overall reaction of the entire SDH complex." The full quinone reduction reaction requires all four subunits (SDHA provides succinate oxidation/FAD reduction, SDHB provides Fe-S electron relay, and SDHC/SDHD provide the quinone binding site). SDHA alone cannot complete the quinone reduction half of the reaction.
Reason: The 'contributes_to' qualifier is arguably more precise than 'enables' for GO:0008177 since the GO definition explicitly states it represents the overall reaction of the entire complex. SDHA provides the succinate dehydrogenase half-reaction (via FAD) but quinone reduction requires the membrane-anchored subunits. The contributes_to qualifier is correct for this complex-level activity; the intrinsic SDHA activity is covered separately by the proposed GO:0000104 annotation.
Supporting Evidence:
PMID:7550341
We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit gene of the succinate dehydrogenase (SDH) in two siblings with complex II deficiency presenting as Leigh syndrome
|
|
GO:0045273
respiratory chain complex II (succinate dehydrogenase)
|
IDA
PMID:37098072 Structure of the human respiratory complex II. |
ACCEPT |
Summary: IDA annotation for Complex II membership from the cryo-EM structure study (Du et al. 2023). This study resolved the human Complex II structure at 2.86A showing all four subunits. SDHA was directly identified in the complex by cryo-EM, SDS-PAGE, and mass spectrometry.
Reason: Direct experimental evidence from cryo-EM structure of human Complex II showing SDHA as a subunit.
Supporting Evidence:
PMID:37098072
We observed all four subunits in a monomeric assembly (Fig. 1A). This arrangement is similar to that in W. succinogenes QFR
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-70994 |
ACCEPT |
Summary: TAS annotation from Reactome for mitochondrial matrix localization. The Reactome entry describes the SDH complex dehydrogenation of succinate, placing SDHA in the matrix.
Reason: Correct. SDHA is on the matrix face of Complex II.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9854672 |
ACCEPT |
Summary: TAS from Reactome for matrix localization, associated with the FAD attachment to SDHA reaction which occurs in the matrix.
Reason: Correct. FAD attachment to SDHA occurs in the mitochondrial matrix.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9854961 |
ACCEPT |
Summary: TAS from Reactome for matrix localization, associated with SDHAF4 binding to FAD-SDHA.
Reason: Correct. SDHAF4 binding to FAD-SDHA occurs in the mitochondrial matrix during Complex II assembly.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9855212 |
ACCEPT |
Summary: TAS from Reactome for matrix localization, associated with SDHA binding to SDHB.
Reason: Correct. SDHA-SDHB subcomplex formation occurs in the matrix.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9855252 |
ACCEPT |
Summary: TAS from Reactome for matrix localization, associated with SDHA:SDHB binding to SDHC:SDHD.
Reason: Correct. The final assembly step of Complex II involves SDHA:SDHB joining SDHC:SDHD at the membrane.
|
|
GO:0008177
succinate dehydrogenase (quinone) activity
|
IMP
PMID:24781757 SDHA mutations causing a multisystem mitochondrial disease: ... |
MODIFY |
Summary: IMP annotation from Renkema et al. (2015) who characterized SDHA mutations causing multisystem mitochondrial disease. They showed that the c.565T>G mutation severely affects enzyme activity and confirmed pathogenicity by lentiviral complementation. This annotation uses 'enables' qualifier (no explicit 'contributes_to' in GOA TSV line).
Reason: Valid IMP evidence showing that SDHA mutations directly impair SDH enzyme activity. The study demonstrates that specific SDHA mutations cause isolated complex II deficiency through impaired catalysis, but the enabled MF should be the intrinsic succinate dehydrogenase activity rather than the whole-complex quinone activity unless the qualifier is contributes_to.
Proposed replacements:
succinate dehydrogenase activity
Supporting Evidence:
PMID:24781757
For the third new mutation, c.565T>G, we show that it severely affects enzyme activity. Its pathogenicity was confirmed by lentiviral complementation experiments on the fibroblasts of patients carrying this mutation
|
|
GO:0005515
protein binding
|
IPI
PMID:23747254 The mitochondrial chaperone TRAP1 promotes neoplastic growth... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with TRAP1 (Q12931) from Sciacovelli et al. (2013). This study showed that the mitochondrial chaperone TRAP1 binds to and inhibits SDH complex (specifically SDHA), leading to succinate accumulation and pseudohypoxic HIF1a stabilization in tumors. This is a functionally significant interaction demonstrated by co-immunoprecipitation, BN-PAGE, and crosslinking experiments.
Reason: The SDHA-TRAP1 interaction is biologically significant (TRAP1 inhibits SDH activity to promote the Warburg effect in tumors), but 'protein binding' remains uninformative. The interaction is regulatory rather than a core molecular function of SDHA.
Supporting Evidence:
PMID:23747254
TRAP1 binds to and inhibits succinate dehydrogenase (SDH), the complex II of the respiratory chain. The respiratory downregulation elicited by TRAP1 interaction with SDH promotes tumorigenesis by priming the succinate-dependent stabilization of the proneoplastic transcription factor HIF1a
|
|
GO:0005743
mitochondrial inner membrane
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation for inner membrane localization by transfer from bovine ortholog (Q0QF01). Consistent with other annotations and cryo-EM evidence.
Reason: Correct. Transfer from well-characterized bovine SDH complex.
|
|
GO:0005515
protein binding
|
IPI
PMID:15961414 Frataxin interacts functionally with mitochondrial electron ... |
KEEP AS NON CORE |
Summary: IPI annotation for interaction with frataxin (Q16595) from Gonzalez-Cabo et al. (2005). This study showed physical interaction between human frataxin and human succinate dehydrogenase complex subunits, suggesting a role for frataxin in the mitochondrial electron transport chain. Frataxin is involved in iron-sulfur cluster biogenesis.
Reason: The SDHA-frataxin interaction is biologically interesting given frataxin's role in Fe-S cluster biogenesis and Friedreich ataxia pathogenesis. However, 'protein binding' is uninformative and this represents a regulatory/assembly interaction rather than a core SDHA function.
Supporting Evidence:
PMID:15961414
We also demonstrate a physical interaction between human frataxin and human succinate dehydrogenase complex subunits, suggesting also a key role of frataxin in the mitochondrial electron transport chain in humans
|
|
GO:0006105
succinate metabolic process
|
IDA
PMID:7550341 Mutation of a nuclear succinate dehydrogenase gene results i... |
ACCEPT |
Summary: IDA annotation for succinate metabolic process from Bourgeron et al. (1995). SDHA catalyzes the oxidation of succinate to fumarate, which is central to succinate metabolism. This is correct but less specific than the TCA cycle annotation.
Reason: Correct. SDHA directly metabolizes succinate as part of its catalytic function. This is a reasonable biological process annotation complementing the TCA cycle and ETC annotations.
|
|
GO:0007399
nervous system development
|
IMP
PMID:16361598 Leigh syndrome caused by mutations in the flavoprotein (Fp) ... |
MARK AS OVER ANNOTATED |
Summary: IMP annotation for nervous system development from Horvath et al. (2006). This study described a child with Leigh syndrome caused by compound heterozygous SDHA mutations (W119X and A83V), presenting with severe progressive neurodegenerative disorder causing epilepsy, psychomotor retardation, and tetraspasticity starting at age five months. The IMP logic is that SDHA mutations cause a neurodevelopmental phenotype, therefore SDHA is involved in nervous system development. However, this is a classic case of over-annotation. SDHA is a housekeeping metabolic enzyme. The nervous system is particularly sensitive to mitochondrial dysfunction due to its high energy demands, but SDHA is not specifically involved in nervous system development. The neurological phenotype is a secondary consequence of impaired cellular energy production, not a direct developmental role for SDHA in neural patterning or differentiation.
Reason: This is a clear over-annotation. SDHA mutations cause Leigh syndrome with neurological features because the nervous system is especially vulnerable to mitochondrial energy deficits, not because SDHA has a specific role in neural development. The nervous system phenotype is a secondary consequence of impaired oxidative phosphorylation. By this logic, any essential metabolic gene causing disease with neurological symptoms would be annotated with 'nervous system development', which is not informative.
Supporting Evidence:
PMID:16361598
The clinical symptoms started at age five months and led to a severe progressive neurodegenerative disorder causing epilepsy, psychomotor retardation, and tetraspasticity. Biochemical measurement of skeletal muscle showed a severe decrease in mitochondrial complex II
|
|
GO:0022904
respiratory electron transport chain
|
IDA
PMID:7550341 Mutation of a nuclear succinate dehydrogenase gene results i... |
ACCEPT |
Summary: IDA annotation for respiratory electron transport chain from Bourgeron et al. (1995). The study showed that SDHA mutation causes complex II deficiency, directly demonstrating SDHA's role in the respiratory electron transport chain. This is broader than GO:0006121 but still accurate.
Reason: Correct. SDHA is part of Complex II which is a component of the respiratory electron transport chain. The Bourgeron et al. study directly demonstrated that SDHA mutation leads to respiratory chain deficiency.
Supporting Evidence:
PMID:7550341
We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit gene of the succinate dehydrogenase (SDH) in two siblings with complex II deficiency presenting as Leigh syndrome
|
|
GO:0005739
mitochondrion
|
IDA
PMID:16826196 Coupling mitochondrial respiratory chain to cell death: an e... |
ACCEPT |
Summary: IDA annotation for mitochondrial localization from Huang et al. (2007). This study was about Complex I and IFN-beta/RA-induced cell death. The connection to SDHA mitochondrial localization is indirect -- the study mentions upregulation of MRC complex subunits but is primarily about Complex I (GRIM-19, NDUFS3). SDHA mitochondrial localization is well-established from other sources regardless.
Reason: Mitochondrial localization of SDHA is beyond question, even though this particular reference is not the strongest evidence for SDHA specifically.
|
|
GO:0005739
mitochondrion
|
IDA
PMID:7550341 Mutation of a nuclear succinate dehydrogenase gene results i... |
ACCEPT |
Summary: IDA annotation for mitochondrial localization from Bourgeron et al. (1995). The study demonstrated mitochondrial respiratory chain deficiency from SDHA mutation, placing SDHA in the mitochondrion.
Reason: Correct mitochondrial localization, supported by the original study showing that SDHA mutation causes mitochondrial respiratory chain deficiency.
|
|
GO:0006099
tricarboxylic acid cycle
|
TAS
PMID:7550341 Mutation of a nuclear succinate dehydrogenase gene results i... |
ACCEPT |
Summary: TAS annotation for TCA cycle from Bourgeron et al. (1995). The study refers to SDH as part of the TCA cycle/respiratory chain.
Reason: Correct. The succinate to fumarate reaction is a canonical TCA cycle step.
|
|
GO:0045273
respiratory chain complex II (succinate dehydrogenase)
|
TAS
PMID:7550341 Mutation of a nuclear succinate dehydrogenase gene results i... |
ACCEPT |
Summary: TAS annotation for Complex II membership from Bourgeron et al. (1995). The study directly discusses Complex II deficiency from SDHA mutation.
Reason: Correct. SDHA is the flavoprotein subunit of Complex II.
|
|
GO:0000104
succinate dehydrogenase activity
|
IDA
PMID:7550341 Mutation of a nuclear succinate dehydrogenase gene results i... |
NEW |
Summary: GO:0000104 (succinate dehydrogenase activity) is defined as "Catalysis of the reaction: succinate + acceptor = fumarate + reduced acceptor." This is a more appropriate molecular function term for SDHA than GO:0008177 (quinone-specific) when annotating the subunit alone, because SDHA catalyzes the succinate to fumarate reaction via its FAD cofactor regardless of the downstream electron acceptor. The Bourgeron et al. study demonstrated that mutation of SDHA impairs succinate dehydrogenase activity. This annotation should use the 'enables' qualifier since SDHA alone (with its FAD cofactor) is sufficient to catalyze succinate oxidation.
Reason: GO:0000104 more precisely captures SDHA's intrinsic catalytic function (succinate oxidation with a generic acceptor) as opposed to GO:0008177 which specifies the quinone-dependent overall complex reaction. SDHA alone can oxidize succinate to fumarate; the FAD cofactor serves as the immediate electron acceptor. This term fills a gap where the current annotations only capture the complex-level activity. Note: GO:0160308 (succinate dehydrogenase (FAD) activity; RHEA:30343) is a more specific child term that explicitly names FAD as the acceptor (FAD + succinate + H+ = fumarate + FADH2). This may be more precise for SDHA since FAD is the actual cofactor. However, GO:0160308 is under consideration for obsolescence. If retained, it would be the preferred term over GO:0000104. The three SDH activity terms form a specificity series: GO:0000104 (generic acceptor, RHEA:16357) > GO:0160308 (FAD, RHEA:30343) and GO:0008177 (quinone, EC:1.3.5.1, RHEA:40523).
Supporting Evidence:
PMID:7550341
The deleterious effect of the Arg to Trp substitution on the catalytic activity of SDH was observed in a SDH- yeast strain transformed with mutant Fp cDNA
|
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Plan status: We verified the target identity (Objective 1) and gathered recent, authoritative sources addressing SDHA biology, complex II organization, disease associations, and diagnostic applications (Objectives 2â6). Below is a comprehensive research report. Because only a subset of requested 2023â2024 literature was retrievable in the current context, some details (e.g., specific imaging protocols) are summarized based on available recent reviews; where evidence is limited, we indicate this.
Comprehensive research report: Human SDHA (UniProt P31040)
1) Key concepts and definitions with current understanding
- Identity and biochemical role: SDHA encodes the flavoprotein (Fp) subunit of mitochondrial complex II (succinate dehydrogenase, SDH). SDHA contains a covalently bound FAD cofactor that catalyzes the oxidation of succinate to fumarate in the tricarboxylic acid (TCA) cycle, while transferring electrons into the mitochondrial electron transport chain via ubiquinone (coenzyme Q) reduction. This places SDHA at the direct intersection of the TCA cycle and oxidative phosphorylation (OXPHOS). (wang2025sdhdefectivecancers pages 1-3)
- Complex II organization: Complex II is a heterotetramer of SDHA and SDHB (matrix-facing catalytic dimer) with SDHC and SDHD forming the membrane-embedded anchor that binds ubiquinone. (wang2025sdhdefectivecancers pages 1-3)
- Assembly factors and FADylation: Dedicated SDH assembly factors (SDHAF1â4) are required. SDHAF2 is specifically implicated in maturation of SDHA by mediating flavin (FAD) acylation/covalent attachment, while SDHAF1/3 support FeâS center insertion into SDHB, and SDHAF4 stabilizes the SDHAâSDHB dimer. (wang2025sdhdefectivecancers pages 1-3)
2) Recent developments and latest research (prioritizing 2023â2024)
- SDH deficiency and oncometabolite signaling: Contemporary reviews synthesize advances showing that succinate accumulation from SDH dysfunction inhibits α-ketoglutarateâdependent enzymes (e.g., HIF prolyl hydroxylases, histone/DNA demethylases), driving pseudohypoxia and epigenetic reprogramming that contribute to tumorigenesis. (wang2025sdhdefectivecancers pages 19-20, wang2025sdhdefectivecancers pages 16-17)
- Post-translational regulation of SDHA: Recent work cataloged tumor-relevant PTMs on SDHA (e.g., phosphorylation Tyr215, acetylation Lys335, succinylation Lys547) and linked mitochondrial protein acylation to metabolic and epigenetic phenotypes in SDH-defective contexts. (wang2025sdhdefectivecancers pages 3-4, wang2025sdhdefectivecancers pages 18-19)
- Broad 2024 perspective on mitochondrial metabolism in cancer: A 2024 review summarizes how alterations in OXPHOS complexes (including complex II/SDHA) interface with cancer biology and therapeutic strategies. (bosso2024targetingthemetabolic pages 32-33)
3) Primary function, substrate specificity, and cellular localization
- Catalyzed reaction and cofactors: SDHA catalyzes succinate oxidation to fumarate using a covalently bound FAD that accepts electrons from succinate; these are relayed through SDHB FeâS centers to ubiquinone bound in SDHC/SDHD, reducing it to ubiquinol. Substrate specificity in humans is succinate (physiologic substrate); fumarate is the reverse substrate under certain conditions, but the physiologic direction in the TCA is succinate â fumarate. (wang2025sdhdefectivecancers pages 1-3)
- Structural organization and interfaces: The SDHA catalytic domain is matrix-facing and associates tightly with SDHB to form the soluble head of complex II; SDHC/SDHD span the inner membrane and provide the ubiquinone-binding pocket and electron exit path. (wang2025sdhdefectivecancers pages 1-3)
- Localization: Complex II resides in the inner mitochondrial membrane. The SDHA active site is exposed to the mitochondrial matrix, consistent with its TCA-cycle role. (wang2025sdhdefectivecancers pages 1-3)
- Assembly and maturation: SDHAF2 supports covalent FAD attachment (FADylation) to SDHA; SDHAF1/3/4 coordinate maturation of the catalytic dimer and FeâS cluster incorporation into SDHB, ensuring competent electron transfer to ubiquinone. (wang2025sdhdefectivecancers pages 1-3)
4) Disease associations, variant spectrum, and recent cohort statistics
- Tumor predisposition: Germline pathogenic variants in SDHx genes (including SDHA) cause hereditary pheochromocytoma/paraganglioma (PPGL) and are also found in SDH-deficient gastrointestinal stromal tumors (GIST), renal cell carcinoma (RCC), and occasional pituitary adenomas. Succinate-driven inhibition of α-KGâdependent dioxygenases links SDH deficiency to pseudohypoxia and a CpG island hypermethylator phenotype. (wang2025sdhdefectivecancers pages 19-20, wang2025sdhdefectivecancers pages 16-17, wang2025sdhdefectivecancers pages 3-4)
- SDH-deficient GIST statistics: SDH-deficient GISTs account for about 10â15% of all GISTs, typically gastric and enriched in pediatric/AYA patients with a female predominance and high distant metastasis rates (reported up to ~82%). Approximately 30% of SDH-deficient GISTs harbor SDHA germline variants; about 50% of the remaining cases are associated with SDHC promoter hypermethylation (SDHC epimutation). (wang2025sdhdefectivecancers pages 3-4)
- PPGL genetics: Around 40% of PPGLs are hereditary, commonly due to germline SDHx variants. Distinct clinical presentations and risks have been documented across SDHB, SDHD, and SDHA mutation carriers. (wang2025sdhdefectivecancers pages 3-4, bosso2024targetingthemetabolic pages 32-33)
- SDH-deficient RCC: Most often associated with SDHB germline mutations (~83% in reported series), with SDHA and SDHD alterations rarer; presents in younger adults (~late 30s to ~40) with characteristic morphology. (wang2025sdhdefectivecancers pages 3-4)
- Primary mitochondrial disease: Pathogenic SDHA variants can cause OXPHOS deficiency and Leigh syndrome spectrum, cardiomyopathy, and leukodystrophies, consistent with SDHâs role in energy metabolism. (wang2025sdhdefectivecancers pages 1-3, bosso2024targetingthemetabolic pages 32-33)
5) Current applications and real-world implementations
- Diagnostic immunohistochemistry (IHC): Loss of SDHB protein by IHC is a robust tumor marker of SDH complex dysfunction and helps triage hereditary testing for SDHB/SDHC/SDHD; patterns of SDHA loss can indicate SDHA-altered tumors. (wang2025sdhdefectivecancers pages 19-20, wang2025sdhdefectivecancers pages 16-17)
- Metabolomic profiling: Succinate accumulation and related metabolomic signatures, including machine-learningâassisted metabolomics, can predict SDH mutational status in tumors, aiding classification and management. (wang2025sdhdefectivecancers pages 19-20)
- Therapeutic implications: Mechanistic insights (succinate-HIF axis; epigenetic consequences) inform emerging strategies such as targeting redox metabolism, α-KGâdependent dioxygenases, or modulating NAD+ biology in specific SDH-deficient tumor subsets; some preclinical and early clinical observations are summarized in recent reviews. (wang2025sdhdefectivecancers pages 18-19, wang2025sdhdefectivecancers pages 15-16)
6) Expert opinions and authoritative analyses
- Integrative 2025 review: A comprehensive review synthesizes complex II structure-function, assembly biology (including SDHAF2âs role in FADylation of SDHA), and the clinical spectrum of SDH deficiency across primary mitochondrial disease and neoplasia; it emphasizes succinateâs role as an oncometabolite and the diagnostic utility of IHC and metabolomics. (wang2025sdhdefectivecancers pages 1-3, wang2025sdhdefectivecancers pages 19-20, wang2025sdhdefectivecancers pages 16-17, wang2025sdhdefectivecancers pages 18-19, wang2025sdhdefectivecancers pages 15-16, wang2025sdhdefectivecancers pages 3-4)
- Contemporary 2024 perspective: A 2024 review highlights SDH/SDHA within the broader OXPHOSâglycolysis axis in cancer and discusses how mitochondrial alterations inform therapeutic strategies. (bosso2024targetingthemetabolic pages 32-33)
7) Relevant statistics and data from recent studies
- SDH-deficient GIST: 10â15% of all GIST; ~30% carry SDHA germline variants; ~50% of non-SDHA SDH-deficient cases attributable to SDHC promoter hypermethylation; frequent gastric location, pediatric/AYA skew, female predominance, and high metastasis rates (up to ~82%). (wang2025sdhdefectivecancers pages 3-4)
- PPGL heritability: Approximately 40% of PPGLs are hereditary, frequently due to SDHx variants. (wang2025sdhdefectivecancers pages 3-4, bosso2024targetingthemetabolic pages 32-33)
Expert synthesis and gaps
- The identity checks pass: SDHA (UniProt P31040) in Homo sapiens is the FAD-dependent catalytic flavoprotein subunit of complex II, consistent with FAD-dependent oxidoreductase family/domain annotations and the literature summarized above. (wang2025sdhdefectivecancers pages 1-3)
- Recent (2023â2024) literature emphasizes SDH deficiency as a driver of tumorigenesis through oncometabolite signaling, epigenetic remodeling, and metabolic rewiring; diagnostic practice increasingly integrates IHC and metabolomics to infer SDH status. While specific cryo-EM updates and detailed imaging protocol data (e.g., 18F-FDG vs 68Ga-DOTATATE performance in SDH-deficient PPGL) were not available in the retrieved context, the cited recent reviews support the overarching mechanistic and clinical framework. (wang2025sdhdefectivecancers pages 19-20, wang2025sdhdefectivecancers pages 16-17, bosso2024targetingthemetabolic pages 32-33)
URLs and publication dates (available entries)
- Wang et al., 2025, Cell Biology & Toxicology (Apr 2025): https://doi.org/10.1007/s10565-025-10022-w (wang2025sdhdefectivecancers pages 1-3, wang2025sdhdefectivecancers pages 19-20, wang2025sdhdefectivecancers pages 16-17, wang2025sdhdefectivecancers pages 18-19, wang2025sdhdefectivecancers pages 15-16, wang2025sdhdefectivecancers pages 3-4)
- Bosso et al., 2024, Biomedicines (Jan 2024): https://doi.org/10.3390/biomedicines12010211 (bosso2024targetingthemetabolic pages 32-33)
Limitations of current context
- Despite targeted searches, we did not retrieve primary 2023â2024 cryo-EM structural papers for human complex II nor detailed cohort guidelines with imaging test characteristics within the current evidence set. The report therefore emphasizes high-confidence, recent reviews and aggregated cohort statistics available in the provided context. Where precise modality performance metrics (e.g., FDG vs DOTATATE) are required, additional targeted sourcing is recommended.
Conclusion
Human SDHA (UniProt P31040) is the mitochondrial matrix-facing, FAD-dependent flavoprotein subunit of complex II that oxidizes succinate to fumarate and feeds electrons to ubiquinone. Its maturation depends on SDHAF2-mediated FADylation and assembly with SDHB/SDHC/SDHD. Germline and somatic alterations in SDHx, including SDHA, underlie primary mitochondrial disease and a spectrum of tumors such as PPGL and SDH-deficient GIST, with recognizable diagnostic patterns via IHC and metabolomics. Recent analyses (2024â2025) refine mechanistic links between succinate accumulation, hypoxia signaling, and epigenetic reprogramming, and point to emerging diagnostic and therapeutic applications. (wang2025sdhdefectivecancers pages 1-3, wang2025sdhdefectivecancers pages 19-20, wang2025sdhdefectivecancers pages 16-17, bosso2024targetingthemetabolic pages 32-33, wang2025sdhdefectivecancers pages 18-19, wang2025sdhdefectivecancers pages 15-16, wang2025sdhdefectivecancers pages 3-4)
References
(wang2025sdhdefectivecancers pages 1-3): Jiaer Wang, Tao Yuan, Bo Yang, Qiaojun He, and Hong Zhu. Sdh defective cancers: molecular mechanisms and treatment strategies. Cell Biology and Toxicology, Apr 2025. URL: https://doi.org/10.1007/s10565-025-10022-w, doi:10.1007/s10565-025-10022-w. This article has 12 citations and is from a peer-reviewed journal.
(wang2025sdhdefectivecancers pages 19-20): Jiaer Wang, Tao Yuan, Bo Yang, Qiaojun He, and Hong Zhu. Sdh defective cancers: molecular mechanisms and treatment strategies. Cell Biology and Toxicology, Apr 2025. URL: https://doi.org/10.1007/s10565-025-10022-w, doi:10.1007/s10565-025-10022-w. This article has 12 citations and is from a peer-reviewed journal.
(wang2025sdhdefectivecancers pages 16-17): Jiaer Wang, Tao Yuan, Bo Yang, Qiaojun He, and Hong Zhu. Sdh defective cancers: molecular mechanisms and treatment strategies. Cell Biology and Toxicology, Apr 2025. URL: https://doi.org/10.1007/s10565-025-10022-w, doi:10.1007/s10565-025-10022-w. This article has 12 citations and is from a peer-reviewed journal.
(wang2025sdhdefectivecancers pages 3-4): Jiaer Wang, Tao Yuan, Bo Yang, Qiaojun He, and Hong Zhu. Sdh defective cancers: molecular mechanisms and treatment strategies. Cell Biology and Toxicology, Apr 2025. URL: https://doi.org/10.1007/s10565-025-10022-w, doi:10.1007/s10565-025-10022-w. This article has 12 citations and is from a peer-reviewed journal.
(wang2025sdhdefectivecancers pages 18-19): Jiaer Wang, Tao Yuan, Bo Yang, Qiaojun He, and Hong Zhu. Sdh defective cancers: molecular mechanisms and treatment strategies. Cell Biology and Toxicology, Apr 2025. URL: https://doi.org/10.1007/s10565-025-10022-w, doi:10.1007/s10565-025-10022-w. This article has 12 citations and is from a peer-reviewed journal.
(bosso2024targetingthemetabolic pages 32-33): Mira Bosso, Dania Haddad, Ashraf Al Madhoun, and Fahd Al-Mulla. Targeting the metabolic paradigms in cancer and diabetes. Biomedicines, Jan 2024. URL: https://doi.org/10.3390/biomedicines12010211, doi:10.3390/biomedicines12010211. This article has 22 citations and is from a poor quality or predatory journal.
(wang2025sdhdefectivecancers pages 15-16): Jiaer Wang, Tao Yuan, Bo Yang, Qiaojun He, and Hong Zhu. Sdh defective cancers: molecular mechanisms and treatment strategies. Cell Biology and Toxicology, Apr 2025. URL: https://doi.org/10.1007/s10565-025-10022-w, doi:10.1007/s10565-025-10022-w. This article has 12 citations and is from a peer-reviewed journal.
---
id: P31040
gene_symbol: SDHA
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
SDHA encodes the flavoprotein (Fp) subunit of succinate dehydrogenase (SDH, Complex
II),
a heterotetrameric enzyme (SDHA/SDHB/SDHC/SDHD) embedded in the mitochondrial inner
membrane.
SDHA contains a covalently bound FAD cofactor (attached at His99) and catalyzes
the oxidation
of succinate to fumarate as part of the TCA cycle. The electrons from succinate
oxidation are
transferred via FAD to the iron-sulfur clusters in SDHB and ultimately to ubiquinone
bound
at the SDHC/SDHD membrane interface, coupling the TCA cycle to the electron transport
chain.
Complex II is unique among OXPHOS complexes in that it does NOT pump protons across
the inner
membrane. SDHA also functions as a tumor suppressor; loss-of-function mutations
cause
paraganglioma/pheochromocytoma (PPGL5) via succinate accumulation and pseudohypoxic
HIF1a
stabilization. Biallelic mutations cause Leigh syndrome, mitochondrial complex II
deficiency,
and dilated cardiomyopathy.
alternative_products:
- name: '1'
id: P31040-1
- name: '2'
id: P31040-2
sequence_note: VSP_055077
- name: '3'
id: P31040-3
sequence_note: VSP_055078
existing_annotations:
# ============================================================
# IBA ANNOTATIONS (phylogenetic inference from GO_Central)
# ============================================================
- term:
id: GO:0008177
label: succinate dehydrogenase (quinone) activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for the overall SDH quinone reductase activity. GO:0008177
is defined as
"the overall reaction of the entire SDH complex" (succinate + quinone -> fumarate
+ quinol).
The IBA uses the qualifier 'enables' which is debatable for a single subunit
of a complex enzyme.
However, SDHA alone can catalyze the succinate -> fumarate half-reaction (the
succinate
dehydrogenase activity per se), and it is the catalytic subunit where the
substrate binding
and FAD-mediated oxidation occurs. The full quinone reduction requires all
four subunits.
The IMP annotation from PMID:7550341 uses 'contributes_to' which is arguably
more precise
for the full quinone-dependent reaction. Nevertheless, IBA annotations are
well-curated
phylogenetic inferences and the 'enables' qualifier is defensible since SDHA
provides the
primary catalytic function of the complex. The deep research review (SDHA-deep-research-falcon.md)
confirms that the FAD cofactor is covalently linked in the SDHA subunit via
a conserved histidine,
essential for catalysis in characterized complex II enzymes.
action: MODIFY
reason: >-
SDHA is the catalytic subunit of SDH complex containing the FAD cofactor and
active site
for succinate oxidation. While the full quinone reduction requires the entire
complex,
SDHA's role is central and catalytic. The IBA is phylogenetically sound, but
the enables qualifier should not be accepted as-is for the whole-complex
quinone reaction. Use an intrinsic succinate dehydrogenase activity term for
SDHA's enabled activity and retain GO:0008177 only with contributes_to.
proposed_replacement_terms:
- id: GO:0000104
label: succinate dehydrogenase activity
supported_by:
- reference_id: PMID:37098072
supporting_text: >-
The active site for succinate-fumarate interconversion is located at the
interface
between the FAD-binding domain and the capping domain
- reference_id: PMID:7550341
supporting_text: >-
We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit
gene
of the succinate dehydrogenase (SDH) in two siblings with complex II deficiency
- reference_id: file:human/SDHA/SDHA-deep-research-falcon.md
supporting_text: >-
Complex II (succinate dehydrogenase, SDH) catalyzes the oxidation of succinate
to fumarate, coupling two-electron transfer via FAD and iron-sulfur centers
to reduce ubiquinone to ubiquinol in the inner mitochondrial membrane
- term:
id: GO:0045273
label: respiratory chain complex II (succinate dehydrogenase)
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation that SDHA is part of respiratory chain complex II. This is
a core structural
annotation for SDHA as the flavoprotein subunit of the SDH/Complex II heterotetramer
(SDHA+SDHB+SDHC+SDHD). Confirmed by cryo-EM structure (PMID:37098072).
action: ACCEPT
reason: >-
SDHA is unambiguously a subunit of Complex II. The cryo-EM structure at 2.86A
shows all
four subunits including SDHA in the complex (PMID:37098072). This is a core
annotation.
supported_by:
- reference_id: PMID:37098072
supporting_text: >-
All the four subunits (SDHA, SDHB, SDHC, and SDHD) were detected by SDS-PAGE
(SI Appendix, Fig. S1D) and mass spectrometry (MS) (SI Appendix, Table
S1).
- term:
id: GO:0050660
label: flavin adenine dinucleotide binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for FAD binding. SDHA contains a covalently bound FAD cofactor
attached at
His99 (Tele-8alpha-FAD histidine). This is confirmed by crystal and cryo-EM
structures
(PMID:32887801, PMID:37098072). Note that GO:0071949 (FAD binding) is also
annotated
via Reactome. GO:0050660 is the more general term. Both are appropriate; this
IBA is correct.
action: ACCEPT
reason: >-
FAD binding is a core molecular function of SDHA. The FAD cofactor is covalently
attached
to His99 and is essential for catalysis. Supported by multiple structural
studies.
supported_by:
- reference_id: PMID:37098072
supporting_text: >-
The hydrophilic head of human CII consists of the flavin adenine dinucleotide
(FAD)-binding protein (SDHA)
- reference_id: PMID:19628817
supporting_text: >-
Sdh5 is required for SDH-dependent respiration and for Sdh1 flavination
(incorporation
of the flavin adenine dinucleotide cofactor)
- term:
id: GO:0006121
label: mitochondrial electron transport, succinate to ubiquinone
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for the specific biological process of electron transport from
succinate to
ubiquinone. This is the defining biological process for Complex II/SDH in
the mitochondrial
electron transport chain. SDHA initiates this process by oxidizing succinate
via FAD and
passing electrons through the iron-sulfur centers of SDHB to ubiquinone at
SDHC/SDHD.
action: ACCEPT
reason: >-
This is a core biological process annotation for SDHA. The electron flow from
succinate
to ubiquinone begins at SDHA's FAD cofactor. This is the defining ETC function
of Complex II.
supported_by:
- reference_id: PMID:37098072
supporting_text: >-
we propose that the human CII succinate- and ubiquinone-binding sites
are likely to be
connected by a similar chain of redox centers
- term:
id: GO:0009055
label: electron transfer activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for electron transfer activity. SDHA is the initial electron
acceptor in
Complex II, receiving electrons from succinate via its FAD cofactor. The electrons
then
transfer through the [2Fe-2S] cluster of SDHB. This is a core molecular function
annotation.
action: ACCEPT
reason: >-
SDHA performs electron transfer as part of the succinate-to-ubiquinone chain.
The FAD cofactor
accepts electrons from succinate and transfers them to the iron-sulfur protein
SDHB.
This is phylogenetically and biochemically well-supported.
supported_by:
- reference_id: PMID:37098072
supporting_text: >-
The edge-to-edge distance between these redox-active prosthetic groups
is less than
14 Ă
(Fig. 3), a distance range that can efficiently support the delivery
of electrons
between these redox centers (22)
# ============================================================
# IEA ANNOTATIONS (electronic/computational)
# ============================================================
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
IEA annotation based on UniProt subcellular location mapping. SDHA is a peripheral
membrane
protein on the matrix side of the inner mitochondrial membrane, as part of
Complex II.
Confirmed by cryo-EM (PMID:37098072) and UniProt subcellular location annotation.
action: ACCEPT
reason: >-
Correct localization. SDHA is the matrix-facing subunit of Complex II which
is anchored
in the inner mitochondrial membrane via SDHC and SDHD. The IEA mapping is
accurate and
consistent with experimental data including the cryo-EM structure.
supported_by:
- reference_id: PMID:37098072
supporting_text: >-
The entire hydrophobic domain contains two membrane-anchored subunits:
SDHC and SDHD
- term:
id: GO:0006099
label: tricarboxylic acid cycle
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation for TCA cycle involvement. SDHA catalyzes step 6 of the TCA
cycle: the
oxidation of succinate to fumarate. This is one of the two core biological
processes
of Complex II (the other being ETC).
action: ACCEPT
reason: >-
TCA cycle involvement is a core function of SDHA. The succinate to fumarate
reaction
is a canonical step of the TCA cycle. Widely supported by literature.
supported_by:
- reference_id: PMID:37098072
supporting_text: >-
Human complex II is a key protein complex that links two essential energy-producing
processes: the tricarboxylic acid cycle and oxidative phosphorylation
- term:
id: GO:0008177
label: succinate dehydrogenase (quinone) activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation for the same SDH quinone activity as the IBA above, inferred
from
combined automated methods (UniProt keyword, InterPro, EC number). Redundant
with the
IBA and IMP annotations but consistent.
action: MODIFY
reason: >-
Consistent with Complex II function, but not acceptable as an enables
annotation for SDHA alone. The quinone-dependent reaction is performed by
the intact heterotetramer; SDHA's enabled activity is the succinate
dehydrogenase half-reaction.
proposed_replacement_terms:
- id: GO:0000104
label: succinate dehydrogenase activity
- term:
id: GO:0016491
label: oxidoreductase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation for general oxidoreductase activity. SDHA catalyzes the oxidation
of
succinate (EC 1.3.5.1), making it an oxidoreductase. This is a correct but
very broad
parent term. The more specific child terms (GO:0008177, GO:0016627) are also
annotated.
action: ACCEPT
reason: >-
Correct but general. It is acceptable for IEA annotations to be broader than
experimental
annotations. The more specific GO:0008177 is also present.
- term:
id: GO:0016627
label: oxidoreductase activity, acting on the CH-CH group of donors
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
IEA annotation from InterPro mapping. SDHA oxidizes succinate to fumarate,
converting
a CH-CH single bond to a C=C double bond. This is an accurate intermediate-level
classification of the catalytic activity.
action: ACCEPT
reason: >-
Correct classification. Succinate oxidation to fumarate involves removal of
two hydrogens
from the CH2-CH2 group to form the trans double bond of fumarate. This InterPro-based
IEA is accurate.
- term:
id: GO:0022900
label: electron transport chain
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
IEA annotation for general electron transport chain involvement from InterPro.
This is
broader than GO:0006121 (mitochondrial electron transport, succinate to ubiquinone)
which is the more specific IBA annotation. Both are correct.
action: ACCEPT
reason: >-
Correct but more general than the IBA annotation GO:0006121. Complex II is
part of the
electron transport chain. Acceptable for IEA to use the broader term.
- term:
id: GO:0050660
label: flavin adenine dinucleotide binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
IEA annotation for FAD binding from InterPro. Redundant with the IBA annotation
for
the same term. Both are correct.
action: ACCEPT
reason: >-
Correct and consistent with the IBA annotation. FAD is covalently bound to
SDHA at His99.
# ============================================================
# IPI ANNOTATIONS (protein-protein interaction)
# ============================================================
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17353931
review:
summary: >-
IPI annotation from large-scale mass spectrometry protein-protein interaction
study
(Ewing et al. 2007). The WITH/FROM field indicates interaction with HLA-B
(P01889).
This is from a high-throughput screen and the biological significance of an
SDHA-HLA-B
interaction is unclear. Likely a non-specific or indirect detection.
action: KEEP_AS_NON_CORE
reason: >-
High-throughput protein-protein interaction data. The SDHA-HLA-B interaction
has no
known biological relevance and is likely an artifact of overexpression-based
mass
spectrometry. Furthermore, 'protein binding' is uninformative as a GO term.
Keep as
non-core.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:19628817
review:
summary: >-
IPI annotation for interaction between SDHA and SDHAF2/SDH5 (Q9NX18). Hao
et al. (2009)
showed that SDH5/SDHAF2 is required for flavination of succinate dehydrogenase.
The
interaction between SDHA and SDHAF2 is essential for covalent FAD attachment.
This is a biologically meaningful interaction confirmed by UniProt (INTERACTION
section)
and multiple studies.
action: KEEP_AS_NON_CORE
reason: >-
The SDHA-SDHAF2 interaction is biologically meaningful (required for FAD cofactor
insertion), but 'protein binding' is too vague. The interaction is better
captured by
the functional context (SDHAF2 is a complex II assembly factor). Keep as non-core
since
the underlying biology is valid even though the GO term is uninformative.
supported_by:
- reference_id: PMID:19628817
supporting_text: >-
Both yeast and human Sdh5 interact with the catalytic subunit of the succinate
dehydrogenase (SDH) complex ... Sdh5 is required for SDH-dependent respiration
and for Sdh1 flavination
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:19688755
review:
summary: >-
IPI annotation for interaction with SDHB (P21912) from LC-MS/MS analysis of
blue native
PAGE-separated complexes. This confirms the well-established SDHA-SDHB interaction
as
part of Complex II assembly.
action: KEEP_AS_NON_CORE
reason: >-
The SDHA-SDHB interaction is a core biochemical feature of Complex II, but
this is already
captured by the CC annotation GO:0045273 (part_of respiratory chain complex
II). The
'protein binding' annotation is uninformative. Keep as non-core.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:24606901
review:
summary: >-
IPI annotation for interaction with SDHB (P21912) from a study on cochaperone
binding
to LYR motifs for iron-sulfur cluster delivery. This relates to Complex II
assembly.
action: KEEP_AS_NON_CORE
reason: >-
Another SDHA-SDHB interaction detected in the context of iron-sulfur cluster
delivery.
Biologically relevant to Complex II assembly but 'protein binding' is uninformative.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:26496610
review:
summary: >-
IPI annotation for interaction with SDHAF2 (Q9NX18) from a quantitative interactome
study
(Hein et al. 2015). Confirms the SDHA-SDHAF2 assembly factor interaction.
action: KEEP_AS_NON_CORE
reason: >-
Confirms the SDHA-SDHAF2 interaction in an independent quantitative study.
Biologically
relevant but 'protein binding' remains uninformative as a GO term.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:26618866
review:
summary: >-
IPI annotation for interaction with CFTR (P13569) from a study on deltaF508-CFTR
interactome remodelling. The biological significance of SDHA-CFTR interaction
is
questionable -- this is likely a non-specific detection in a large-scale study.
action: KEEP_AS_NON_CORE
reason: >-
The SDHA-CFTR interaction is of unclear biological significance. CFTR is an
ABC
transporter involved in chloride conductance, and its interaction with a mitochondrial
enzyme is likely indirect or an artifact. Keep as non-core.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:26749241
review:
summary: >-
IPI annotation for interaction with SDHB (P21912) from a study on SDHAF1 mutations
impairing Fe-S cluster transfer to SDHB. Relevant to Complex II assembly.
action: KEEP_AS_NON_CORE
reason: >-
SDHA-SDHB interaction confirmed in the context of Fe-S cluster assembly. Biologically
meaningful but 'protein binding' is uninformative. Already captured by CC
annotation.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28330616
review:
summary: >-
IPI annotation for interaction with PTPN3 (P26045) from systematic analysis
of human
protein phosphatase interactions. The biological relevance of an SDHA-PTPN3
interaction
is unclear. PTPN3 is a tyrosine phosphatase. SDHA is known to be phosphorylated
at
Tyr-215 by SRC, so a phosphatase interaction could be biologically relevant
but is
not well characterized.
action: KEEP_AS_NON_CORE
reason: >-
High-throughput phosphatase interaction study. While SDHA is phosphorylated
at Y215,
the specific relevance of PTPN3 interaction is not established.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
review:
summary: >-
IPI annotation for interaction with SDHB (P21912) from architecture of the
human
interactome study (Huttlin et al. 2017). Confirms SDHA-SDHB subunit interaction.
action: KEEP_AS_NON_CORE
reason: >-
Another confirmation of the SDHA-SDHB interaction. Already well established
and
captured by the CC annotation for Complex II membership.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
review:
summary: >-
IPI annotation for interaction with SDHAF2 (Q9NX18) from the same architecture
of
the human interactome study (Huttlin et al. 2017). This is the second GOA
entry for
this PMID, detecting the SDHA-SDHAF2 assembly factor interaction.
action: KEEP_AS_NON_CORE
reason: >-
Confirms the SDHA-SDHAF2 interaction. SDHAF2 is the assembly factor required
for
FAD insertion into SDHA. Biologically meaningful but 'protein binding' is
uninformative.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:29128334
review:
summary: >-
IPI annotation for interaction with HLA-B (P01889) from mitochondrial protein
interaction
map linked to neurodegeneration. Same interactor as PMID:17353931. The biological
significance of SDHA-HLA-B interaction remains unclear.
action: KEEP_AS_NON_CORE
reason: >-
Second independent detection of SDHA-HLA-B interaction, but the biological
relevance
remains unclear. HLA-B is an MHC class I molecule, not expected to functionally
interact
with a mitochondrial matrix enzyme.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:29924966
review:
summary: >-
IPI annotation for interaction with CFTR (P13569) from a proteomic variant
approach study.
Second SDHA-CFTR interaction, of unclear biological significance.
action: KEEP_AS_NON_CORE
reason: >-
SDHA-CFTR interaction detected by proteomics. Unclear biological significance.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:31324722
review:
summary: >-
IPI annotation for interaction with CFTR (P13569) from study on calpain 1
and
Phe508del-CFTR. Third SDHA-CFTR interaction detection. Multiple detections
suggest
a real physical interaction but its functional significance for SDHA is unclear.
action: KEEP_AS_NON_CORE
reason: >-
Third detection of SDHA-CFTR interaction. While multiple detections suggest
a real
interaction, the functional significance for SDHA function is unclear.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
review:
summary: >-
IPI annotation for interaction with SDHB (P21912) from dual proteome-scale
network
study (Huttlin et al. 2021). Confirms the known Complex II SDHA-SDHB subunit
interaction.
action: KEEP_AS_NON_CORE
reason: >-
Confirms the SDHA-SDHB interaction. Well established and captured by CC annotation.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
review:
summary: >-
IPI annotation for interaction with SDHAF2 (Q9NX18) from dual proteome-scale
network
study (Huttlin et al. 2021). This is the second GOA entry for this PMID, confirming
the SDHA-SDHAF2 assembly factor interaction.
action: KEEP_AS_NON_CORE
reason: >-
Confirms the SDHA-SDHAF2 interaction. Well established.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:35156780
review:
summary: >-
IPI annotation for interaction with CFTR (P13569) from membrane two-hybrid
screening.
Fourth SDHA-CFTR interaction detection.
action: KEEP_AS_NON_CORE
reason: >-
Yet another SDHA-CFTR detection. While robust, CFTR interaction is not relevant
to
the core function of SDHA.
# ============================================================
# LOCALIZATION ANNOTATIONS
# ============================================================
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation for mitochondrial localization via Ensembl Compara ortholog
transfer.
SDHA has a mitochondrial transit peptide (residues 1-42) and is localized
to the
mitochondrial matrix as part of Complex II.
action: ACCEPT
reason: >-
Correct localization, well supported by multiple lines of evidence including
the transit peptide and IDA evidence.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation for mitochondrial matrix localization via Ensembl Compara ortholog
transfer.
SDHA faces the matrix side of the inner membrane as a peripheral membrane
protein.
action: ACCEPT
reason: >-
Correct. SDHA is on the matrix side of the inner mitochondrial membrane, confirmed
by cryo-EM structure (PMID:37098072) showing SDHA in the hydrophilic head
of Complex II
facing the matrix.
supported_by:
- reference_id: PMID:37098072
supporting_text: >-
The hydrophilic head of human CII consists of the flavin adenine dinucleotide
(FAD)-binding protein (SDHA) and the iron-sulfur protein (SDHB)
- term:
id: GO:0045273
label: respiratory chain complex II (succinate dehydrogenase)
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation for Complex II membership via Ensembl Compara ortholog transfer.
Redundant with IBA and other annotations for the same term.
action: ACCEPT
reason: >-
Correct and consistent with IBA, ISS, IDA, and TAS annotations for this term.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: >-
IDA annotation for mitochondrial localization from HPA immunofluorescence
data.
Direct experimental evidence of SDHA mitochondrial localization.
action: ACCEPT
reason: >-
Direct experimental evidence of mitochondrial localization by immunofluorescence.
- term:
id: GO:0006099
label: tricarboxylic acid cycle
evidence_type: TAS
original_reference_id: Reactome:R-HSA-71403
review:
summary: >-
TAS annotation from Reactome TCA cycle pathway. SDHA participates in the TCA
cycle
by catalyzing the succinate to fumarate step.
action: ACCEPT
reason: >-
Core function annotation. Consistent with IEA and NAS annotations for the
same term.
SDHA is a canonical TCA cycle enzyme.
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: NAS
original_reference_id: PMID:30030361
review:
summary: >-
NAS annotation from ComplexPortal based on review by Signes and Fernandez-Vizarra
(2018)
on assembly of OXPHOS complexes. SDHA is part of Complex II which is embedded
in the
inner mitochondrial membrane.
action: ACCEPT
reason: >-
Correct localization. Complex II spans the inner membrane via SDHC/SDHD subunits,
with
SDHA on the matrix side as a peripheral membrane protein.
- term:
id: GO:0006099
label: tricarboxylic acid cycle
evidence_type: NAS
original_reference_id: PMID:30030361
review:
summary: >-
NAS annotation from ComplexPortal for TCA cycle involvement. Redundant with
other
TCA cycle annotations but consistent.
action: ACCEPT
reason: >-
Correct and consistent with other TCA cycle annotations from Reactome and
IEA sources.
- term:
id: GO:0006121
label: mitochondrial electron transport, succinate to ubiquinone
evidence_type: NAS
original_reference_id: PMID:30030361
review:
summary: >-
NAS annotation from ComplexPortal for the specific ETC process. Consistent
with the
IBA annotation for the same term.
action: ACCEPT
reason: >-
Correct. This is a core biological process for SDHA/Complex II.
- term:
id: GO:0042776
label: proton motive force-driven mitochondrial ATP synthesis
evidence_type: NAS
original_reference_id: PMID:30030361
review:
summary: >-
NAS annotation from ComplexPortal suggesting SDHA is involved in proton motive
force-driven mitochondrial ATP synthesis. This annotation is problematic because
Complex II does NOT pump protons across the inner mitochondrial membrane.
Unlike
Complexes I, III, and IV which translocate protons to generate the proton
motive force,
Complex II transfers electrons from succinate to ubiquinone without any proton
pumping.
Complex II contributes to ATP synthesis only indirectly by feeding reduced
ubiquinol
into the Q pool, which is then oxidized by Complex III (which does pump protons).
Annotating SDHA with this term conflates electron donation to the Q pool with
proton
translocation.
action: REMOVE
reason: >-
Complex II is the only OXPHOS complex that does NOT pump protons. The proton
motive
force is generated by Complexes I, III, and IV. Complex II feeds electrons
into the
ubiquinone pool but does not directly contribute to the proton gradient. This
annotation
is misleading and should be removed. The correct process annotation for SDHA
is
GO:0006121 (mitochondrial electron transport, succinate to ubiquinone).
supported_by:
- reference_id: PMID:37098072
supporting_text: >-
The respiratory chain (also called electron transport chain) consists
of complexes I-IV.
It oxidizes the reducing equivalents in nicotinamide adenine dinucleotide
(NADH) and
succinate using molecular oxygen and couples the translocation of protons
from the
mitochondrial matrix into the intermembrane space
# [Note: This passage describes the overall respiratory chain but the proton translocation
# is performed by CI, CIII, CIV -- not CII. CII transfers electrons but does not pump protons.]
- term:
id: GO:0071949
label: FAD binding
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9854672
review:
summary: >-
TAS annotation from Reactome for FAD binding. The Reactome entry R-HSA-9854672
describes the covalent attachment of FAD to SDHA. GO:0071949 (FAD binding)
specifically
refers to binding the oxidized form of FAD, which is appropriate for SDHA.
action: ACCEPT
reason: >-
Correct. SDHA covalently binds FAD at His99. This is the more specific FAD
binding term
compared to GO:0050660, and both are appropriate. Reactome accurately captures
this step
of Complex II maturation.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HTP
original_reference_id: PMID:34800366
review:
summary: >-
HTP annotation for mitochondrial localization from a quantitative high-confidence
human
mitochondrial proteome study (Morgenstern et al. 2021). SDHA was identified
in the
mitochondrial proteome.
action: ACCEPT
reason: >-
Correct. SDHA is a well-established mitochondrial protein confirmed by proteomics.
- term:
id: GO:0045273
label: respiratory chain complex II (succinate dehydrogenase)
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for Complex II membership by manual transfer from bovine ortholog
(Q0QF01). Consistent with all other annotations for this term.
action: ACCEPT
reason: >-
Correct. Transfer from the well-characterized bovine SDH complex.
# ============================================================
# KEY EXPERIMENTAL ANNOTATIONS
# ============================================================
- term:
id: GO:0008177
label: succinate dehydrogenase (quinone) activity
evidence_type: IMP
original_reference_id: PMID:7550341
qualifier: contributes_to
review:
summary: >-
IMP annotation with 'contributes_to' qualifier from the landmark Bourgeron
et al. (1995)
study. This study identified the first nuclear gene mutation causing mitochondrial
respiratory chain deficiency -- an Arg554Trp mutation in SDHA causing Leigh
syndrome
with complex II deficiency. The 'contributes_to' qualifier is appropriate
for GO:0008177
since the GO term definition states "This term represents the overall reaction
of the
entire SDH complex." The full quinone reduction reaction requires all four
subunits
(SDHA provides succinate oxidation/FAD reduction, SDHB provides Fe-S electron
relay,
and SDHC/SDHD provide the quinone binding site). SDHA alone cannot complete
the quinone
reduction half of the reaction.
action: ACCEPT
reason: >-
The 'contributes_to' qualifier is arguably more precise than 'enables' for
GO:0008177
since the GO definition explicitly states it represents the overall reaction
of the
entire complex. SDHA provides the succinate dehydrogenase half-reaction (via
FAD) but
quinone reduction requires the membrane-anchored subunits. The contributes_to
qualifier is correct for this complex-level activity; the intrinsic SDHA
activity is covered separately by the proposed GO:0000104 annotation.
supported_by:
- reference_id: PMID:7550341
supporting_text: >-
We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit
gene of the
succinate dehydrogenase (SDH) in two siblings with complex II deficiency
presenting
as Leigh syndrome
- term:
id: GO:0045273
label: respiratory chain complex II (succinate dehydrogenase)
evidence_type: IDA
original_reference_id: PMID:37098072
review:
summary: >-
IDA annotation for Complex II membership from the cryo-EM structure study
(Du et al. 2023).
This study resolved the human Complex II structure at 2.86A showing all four
subunits.
SDHA was directly identified in the complex by cryo-EM, SDS-PAGE, and mass
spectrometry.
action: ACCEPT
reason: >-
Direct experimental evidence from cryo-EM structure of human Complex II showing
SDHA
as a subunit.
supported_by:
- reference_id: PMID:37098072
supporting_text: >-
We observed all four subunits in a monomeric assembly (Fig. 1A). This
arrangement
is similar to that in W. succinogenes QFR
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-70994
review:
summary: >-
TAS annotation from Reactome for mitochondrial matrix localization. The Reactome
entry
describes the SDH complex dehydrogenation of succinate, placing SDHA in the
matrix.
action: ACCEPT
reason: >-
Correct. SDHA is on the matrix face of Complex II.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9854672
review:
summary: >-
TAS from Reactome for matrix localization, associated with the FAD attachment
to SDHA
reaction which occurs in the matrix.
action: ACCEPT
reason: >-
Correct. FAD attachment to SDHA occurs in the mitochondrial matrix.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9854961
review:
summary: >-
TAS from Reactome for matrix localization, associated with SDHAF4 binding
to FAD-SDHA.
action: ACCEPT
reason: >-
Correct. SDHAF4 binding to FAD-SDHA occurs in the mitochondrial matrix during
Complex II
assembly.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9855212
review:
summary: >-
TAS from Reactome for matrix localization, associated with SDHA binding to
SDHB.
action: ACCEPT
reason: >-
Correct. SDHA-SDHB subcomplex formation occurs in the matrix.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9855252
review:
summary: >-
TAS from Reactome for matrix localization, associated with SDHA:SDHB binding
to SDHC:SDHD.
action: ACCEPT
reason: >-
Correct. The final assembly step of Complex II involves SDHA:SDHB joining
SDHC:SDHD
at the membrane.
- term:
id: GO:0008177
label: succinate dehydrogenase (quinone) activity
evidence_type: IMP
original_reference_id: PMID:24781757
review:
summary: >-
IMP annotation from Renkema et al. (2015) who characterized SDHA mutations
causing
multisystem mitochondrial disease. They showed that the c.565T>G mutation
severely
affects enzyme activity and confirmed pathogenicity by lentiviral complementation.
This annotation uses 'enables' qualifier (no explicit 'contributes_to' in
GOA TSV line).
action: MODIFY
reason: >-
Valid IMP evidence showing that SDHA mutations directly impair SDH enzyme
activity.
The study demonstrates that specific SDHA mutations cause isolated complex
II deficiency through impaired catalysis, but the enabled MF should be the
intrinsic succinate dehydrogenase activity rather than the whole-complex
quinone activity unless the qualifier is contributes_to.
proposed_replacement_terms:
- id: GO:0000104
label: succinate dehydrogenase activity
supported_by:
- reference_id: PMID:24781757
supporting_text: >-
For the third new mutation, c.565T>G, we show that it severely affects
enzyme activity.
Its pathogenicity was confirmed by lentiviral complementation experiments
on the
fibroblasts of patients carrying this mutation
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:23747254
review:
summary: >-
IPI annotation for interaction with TRAP1 (Q12931) from Sciacovelli et al.
(2013).
This study showed that the mitochondrial chaperone TRAP1 binds to and inhibits
SDH
complex (specifically SDHA), leading to succinate accumulation and pseudohypoxic
HIF1a stabilization in tumors. This is a functionally significant interaction
demonstrated
by co-immunoprecipitation, BN-PAGE, and crosslinking experiments.
action: KEEP_AS_NON_CORE
reason: >-
The SDHA-TRAP1 interaction is biologically significant (TRAP1 inhibits SDH
activity
to promote the Warburg effect in tumors), but 'protein binding' remains uninformative.
The interaction is regulatory rather than a core molecular function of SDHA.
supported_by:
- reference_id: PMID:23747254
supporting_text: >-
TRAP1 binds to and inhibits succinate dehydrogenase (SDH), the complex
II of the
respiratory chain. The respiratory downregulation elicited by TRAP1 interaction
with SDH promotes tumorigenesis by priming the succinate-dependent stabilization
of the proneoplastic transcription factor HIF1a
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for inner membrane localization by transfer from bovine ortholog
(Q0QF01).
Consistent with other annotations and cryo-EM evidence.
action: ACCEPT
reason: >-
Correct. Transfer from well-characterized bovine SDH complex.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:15961414
review:
summary: >-
IPI annotation for interaction with frataxin (Q16595) from Gonzalez-Cabo et
al. (2005).
This study showed physical interaction between human frataxin and human succinate
dehydrogenase complex subunits, suggesting a role for frataxin in the mitochondrial
electron transport chain. Frataxin is involved in iron-sulfur cluster biogenesis.
action: KEEP_AS_NON_CORE
reason: >-
The SDHA-frataxin interaction is biologically interesting given frataxin's
role in
Fe-S cluster biogenesis and Friedreich ataxia pathogenesis. However, 'protein
binding'
is uninformative and this represents a regulatory/assembly interaction rather
than a
core SDHA function.
supported_by:
- reference_id: PMID:15961414
supporting_text: >-
We also demonstrate a physical interaction between human frataxin and
human succinate
dehydrogenase complex subunits, suggesting also a key role of frataxin
in the
mitochondrial electron transport chain in humans
- term:
id: GO:0006105
label: succinate metabolic process
evidence_type: IDA
original_reference_id: PMID:7550341
review:
summary: >-
IDA annotation for succinate metabolic process from Bourgeron et al. (1995).
SDHA
catalyzes the oxidation of succinate to fumarate, which is central to succinate
metabolism. This is correct but less specific than the TCA cycle annotation.
action: ACCEPT
reason: >-
Correct. SDHA directly metabolizes succinate as part of its catalytic function.
This is a reasonable biological process annotation complementing the TCA cycle
and ETC annotations.
- term:
id: GO:0007399
label: nervous system development
evidence_type: IMP
original_reference_id: PMID:16361598
review:
summary: >-
IMP annotation for nervous system development from Horvath et al. (2006).
This study
described a child with Leigh syndrome caused by compound heterozygous SDHA
mutations
(W119X and A83V), presenting with severe progressive neurodegenerative disorder
causing
epilepsy, psychomotor retardation, and tetraspasticity starting at age five
months.
The IMP logic is that SDHA mutations cause a neurodevelopmental phenotype,
therefore
SDHA is involved in nervous system development. However, this is a classic
case of
over-annotation. SDHA is a housekeeping metabolic enzyme. The nervous system
is particularly
sensitive to mitochondrial dysfunction due to its high energy demands, but
SDHA is not
specifically involved in nervous system development. The neurological phenotype
is a
secondary consequence of impaired cellular energy production, not a direct
developmental
role for SDHA in neural patterning or differentiation.
action: MARK_AS_OVER_ANNOTATED
reason: >-
This is a clear over-annotation. SDHA mutations cause Leigh syndrome with
neurological
features because the nervous system is especially vulnerable to mitochondrial
energy
deficits, not because SDHA has a specific role in neural development. The
nervous system
phenotype is a secondary consequence of impaired oxidative phosphorylation.
By this logic,
any essential metabolic gene causing disease with neurological symptoms would
be annotated
with 'nervous system development', which is not informative.
supported_by:
- reference_id: PMID:16361598
supporting_text: >-
The clinical symptoms started at age five months and led to a severe progressive
neurodegenerative disorder causing epilepsy, psychomotor retardation,
and
tetraspasticity. Biochemical measurement of skeletal muscle showed a severe
decrease in mitochondrial complex II
- term:
id: GO:0022904
label: respiratory electron transport chain
evidence_type: IDA
original_reference_id: PMID:7550341
review:
summary: >-
IDA annotation for respiratory electron transport chain from Bourgeron et
al. (1995).
The study showed that SDHA mutation causes complex II deficiency, directly
demonstrating
SDHA's role in the respiratory electron transport chain. This is broader than
GO:0006121
but still accurate.
action: ACCEPT
reason: >-
Correct. SDHA is part of Complex II which is a component of the respiratory
electron
transport chain. The Bourgeron et al. study directly demonstrated that SDHA
mutation
leads to respiratory chain deficiency.
supported_by:
- reference_id: PMID:7550341
supporting_text: >-
We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit
gene
of the succinate dehydrogenase (SDH) in two siblings with complex II deficiency
presenting as Leigh syndrome
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:16826196
review:
summary: >-
IDA annotation for mitochondrial localization from Huang et al. (2007). This
study
was about Complex I and IFN-beta/RA-induced cell death. The connection to
SDHA
mitochondrial localization is indirect -- the study mentions upregulation
of MRC
complex subunits but is primarily about Complex I (GRIM-19, NDUFS3). SDHA
mitochondrial localization is well-established from other sources regardless.
action: ACCEPT
reason: >-
Mitochondrial localization of SDHA is beyond question, even though this particular
reference is not the strongest evidence for SDHA specifically.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:7550341
review:
summary: >-
IDA annotation for mitochondrial localization from Bourgeron et al. (1995).
The study
demonstrated mitochondrial respiratory chain deficiency from SDHA mutation,
placing
SDHA in the mitochondrion.
action: ACCEPT
reason: >-
Correct mitochondrial localization, supported by the original study showing
that SDHA
mutation causes mitochondrial respiratory chain deficiency.
- term:
id: GO:0006099
label: tricarboxylic acid cycle
evidence_type: TAS
original_reference_id: PMID:7550341
review:
summary: >-
TAS annotation for TCA cycle from Bourgeron et al. (1995). The study refers
to SDH
as part of the TCA cycle/respiratory chain.
action: ACCEPT
reason: >-
Correct. The succinate to fumarate reaction is a canonical TCA cycle step.
- term:
id: GO:0045273
label: respiratory chain complex II (succinate dehydrogenase)
evidence_type: TAS
original_reference_id: PMID:7550341
review:
summary: >-
TAS annotation for Complex II membership from Bourgeron et al. (1995). The
study
directly discusses Complex II deficiency from SDHA mutation.
action: ACCEPT
reason: >-
Correct. SDHA is the flavoprotein subunit of Complex II.
# ============================================================
# NEW ANNOTATIONS (missing from current set)
# ============================================================
- term:
id: GO:0000104
label: succinate dehydrogenase activity
evidence_type: IDA
original_reference_id: PMID:7550341
review:
summary: >-
GO:0000104 (succinate dehydrogenase activity) is defined as "Catalysis of
the reaction:
succinate + acceptor = fumarate + reduced acceptor." This is a more appropriate
molecular
function term for SDHA than GO:0008177 (quinone-specific) when annotating
the subunit
alone, because SDHA catalyzes the succinate to fumarate reaction via its FAD
cofactor
regardless of the downstream electron acceptor. The Bourgeron et al. study
demonstrated
that mutation of SDHA impairs succinate dehydrogenase activity. This annotation
should
use the 'enables' qualifier since SDHA alone (with its FAD cofactor) is sufficient
to
catalyze succinate oxidation.
action: NEW
reason: >-
GO:0000104 more precisely captures SDHA's intrinsic catalytic function (succinate
oxidation with a generic acceptor) as opposed to GO:0008177 which specifies
the
quinone-dependent overall complex reaction. SDHA alone can oxidize succinate
to
fumarate; the FAD cofactor serves as the immediate electron acceptor. This
term
fills a gap where the current annotations only capture the complex-level activity.
Note: GO:0160308 (succinate dehydrogenase (FAD) activity; RHEA:30343) is a more
specific child term that explicitly names FAD as the acceptor (FAD + succinate + H+
= fumarate + FADH2). This may be more precise for SDHA since FAD is the actual
cofactor. However, GO:0160308 is under consideration for obsolescence. If retained,
it would be the preferred term over GO:0000104. The three SDH activity terms form
a specificity series: GO:0000104 (generic acceptor, RHEA:16357) > GO:0160308
(FAD, RHEA:30343) and GO:0008177 (quinone, EC:1.3.5.1, RHEA:40523).
supported_by:
- reference_id: PMID:7550341
supporting_text: >-
The deleterious effect of the Arg to Trp substitution on the catalytic
activity
of SDH was observed in a SDH- yeast strain transformed with mutant Fp
cDNA
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to
orthologs by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied
by UniProt
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data
to orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:15961414
title: Frataxin interacts functionally with mitochondrial electron transport chain
proteins.
findings:
- statement: >-
Frataxin physically interacts with succinate dehydrogenase complex subunits
SDHA
and SDHB in both yeast and humans, suggesting a role for frataxin in the
mitochondrial
electron transport chain.
supporting_text: >-
We also demonstrate a physical interaction between human frataxin and human
succinate
dehydrogenase complex subunits, suggesting also a key role of frataxin in
the
mitochondrial electron transport chain in humans
- id: PMID:16361598
title: Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of
succinate dehydrogenase (SDHA).
findings:
- statement: >-
Compound heterozygous SDHA mutations (W119X nonsense in exon 4 and A83V
missense in
exon 3) cause Leigh syndrome with severe complex II deficiency demonstrated
by
biochemical measurement in skeletal muscle.
supporting_text: >-
Biochemical measurement of skeletal muscle showed a severe decrease in mitochondrial
complex II. Sequencing of SDHA revealed compound heterozygosity for a nonsense
mutation in exon 4 (W119X) and a missense mutation in exon 3 (A83V), both
absent
in normal controls.
reference_section_type: ABSTRACT
full_text_unavailable: true
- statement: >-
Genetic heterogeneity exists for isolated complex II deficiency; six additional
patients with Leigh or Leigh-like syndrome and complex II deficiency did
not harbor
SDHA mutations.
supporting_text: >-
In six additional patients--five with Leigh or Leigh-like syndrome and one
with
neuropathy and ataxia associated with isolated deficiency of complex II--mutations
in SDHA were not detected, indicating genetic heterogeneity.
reference_section_type: ABSTRACT
full_text_unavailable: true
- id: PMID:16826196
title: 'Coupling mitochondrial respiratory chain to cell death: an essential role
of mitochondrial complex I in the interferon-beta and retinoic acid-induced
cancer cell death.'
findings:
- statement: >-
IFN-beta/RA upregulates expression of mitochondrial respiratory chain complex
subunits.
Study is primarily about Complex I (GRIM-19, NDUFS3); SDHA relevance is
indirect,
as the study demonstrates that MRC upregulation drives ROS-mediated cancer
cell death.
supporting_text: >-
We found that IFN-beta/RA upregulates the expression of MRC complex subunits.
Mitochondrial-nuclear translocation of these subunits was not observed,
but
overproduction of reactive oxygen species (ROS), which causes loss of mitochondrial
function, was detected upon IFN-beta/RA treatment.
reference_section_type: ABSTRACT
full_text_unavailable: true
- id: PMID:17353931
title: Large-scale mapping of human protein-protein interactions by mass spectrometry.
findings: []
- id: PMID:19628817
title: SDH5, a gene required for flavination of succinate dehydrogenase, is mutated
in paraganglioma.
findings:
- statement: >-
SDH5/SDHAF2 physically interacts with the catalytic subunit of the SDH complex
(Sdh1 in yeast, SDHA in humans) and is required for covalent flavination,
i.e.
incorporation of the FAD cofactor into the flavoprotein subunit.
supporting_text: >-
Both yeast and human Sdh5 interact with the catalytic subunit of the succinate
dehydrogenase (SDH) complex, a component of both the electron transport
chain and
the tricarboxylic acid cycle. Sdh5 is required for SDH-dependent respiration
and
for Sdh1 flavination (incorporation of the flavin adenine dinucleotide cofactor).
reference_section_type: ABSTRACT
full_text_unavailable: true
- statement: >-
Germline loss-of-function mutations in human SDH5/SDHAF2 segregate with
hereditary
paraganglioma, linking SDHA flavination assembly to tumor suppression.
supporting_text: >-
Germline loss-of-function mutations in the human SDH5 gene, located on chromosome
11q13.1, segregate with disease in a family with hereditary paraganglioma,
a
neuroendocrine tumor previously linked to mutations in genes encoding SDH
subunits.
reference_section_type: ABSTRACT
full_text_unavailable: true
- id: PMID:19688755
title: LC-MS/MS as an alternative for SDS-PAGE in blue native analysis of protein
complexes.
findings: []
- id: PMID:23747254
title: The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting
succinate dehydrogenase.
findings:
- statement: >-
TRAP1 physically interacts with SDH complex II, confirmed by co-immunoprecipitation,
BN-PAGE, and chemical crosslinking. Two distinct TRAP1/SDH complexes are
formed
in mitochondria.
supporting_text: We confirmed the interaction between TRAP1 and complex II/SDH
through further approaches, including (1) immunoprecipitation, finding coimmunoprecipitation
(coIP) of TRAP1 with SDH and vice versa (Figure 3C), and (2) mitochondrial
protein crosslinking with dimethyl 3,3âČ-dithiobis-propionimidate (DTBP),
a homobifunctional compound that reacts with the primary amines of two interacting
proteins at an average distance of about 8Â Ă
(Giorgio et al., 2009), followed
by TRAP1 immunoprecipitation in order to determine whether TRAP1 and SDH
are closely associated. We found that two TRAP1/SDH complexes are formed
in mitochondria (Figure 3D).
reference_section_type: RESULTS
full_text_unavailable: false
- statement: >-
TRAP1 knockdown increases SQR enzymatic activity without affecting complex
II protein
levels. TRAP1 re-expression restores inhibition, and the Hsp90 inhibitor
17-AAG
reverses TRAP1-mediated SDH inhibition, demonstrating the inhibition is
reversible.
supporting_text: >-
We found that SQR enzymatic activity was increased in mitochondria from
shTRAP1
cells relative to those derived from control cells (Figures 4A, S2A, and
S2B).
TRAP1 did not affect either the cytochrome oxidase enzymatic activity of
complex IV
(Figure S2C) or complex II protein levels (Figure S2D) or mitochondrial
mass
(Figure S2E).
reference_section_type: RESULTS
full_text_unavailable: false
- statement: >-
TRAP1-mediated SDH inhibition causes intracellular succinate accumulation
and
pseudohypoxic HIF1a stabilization (independent of oxygen deprivation),
establishing a mechanism for the Warburg effect in tumors via SDH regulation.
supporting_text: We observe that TRAP1-mediated inhibition of SDH limits the
maximal rate of respiration and leads to succinate accumulation followed
by HIF1α, but not HIF2α, stabilization. Remarkably, the membrane-permeable
succinate analog dimethyl succinate could both elicit HIF1α stabilization
and rescue the tumorigenic phenotype of shTRAP1 cells, highlighting the
mechanistic connection between TRAP1-dependent succinate accumulation and
HIF1α-dependent tumor formation.
reference_section_type: DISCUSSION
full_text_unavailable: false
- statement: >-
The SDH inhibitor 3-nitropropionic acid (3-NP) inactivates SDH by covalent
binding
with an Arg residue in the catalytic core of SDHA, confirming SDHA as the
site of
catalytic activity in Complex II.
supporting_text: >-
A low concentration of the ETC complex II inhibitors 3-nitropropionic acid
(3-NP),
which inactivates SDH after covalent binding with an Arg residue in the
catalytic
core of SDHA (Huang et al., 2006), or thenoyltrifluoroacetone (TTFA), which
blocks
electron transfer from succinate to coenzyme Q at the quinone-binding site
in
subunits B and D (Huang et al., 2006), inhibited OCR in shTRAP1 cells but
were
inactive in the presence of TRAP1 (Figures S4B and S4C), paralleling the
downmodulation of the SQR activity induced by 3-NP only in TRAP1-expressing
mitochondria (Figure 5E).
reference_section_type: RESULTS
full_text_unavailable: false
- id: PMID:24606901
title: Cochaperone binding to LYR motifs confers specificity of iron sulfur cluster
delivery.
findings: []
- id: PMID:24781757
title: 'SDHA mutations causing a multisystem mitochondrial disease: novel mutations
and genetic overlap with hereditary tumors.'
findings:
- statement: >-
Novel SDHA mutations causing isolated complex II deficiency with Leigh syndrome
and leukodystrophy. Mutation c.565T>G severely affects enzyme activity,
confirmed
by lentiviral complementation. Genetic overlap between mitochondrial disease
and
hereditary tumor mutations in SDHA.
- id: PMID:26496610
title: A human interactome in three quantitative dimensions organized by stoichiometries
and abundances.
findings: []
- id: PMID:26618866
title: âF508 CFTR interactome remodelling promotes rescue of cystic fibrosis.
findings: []
- id: PMID:26749241
title: Disease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clusters to SDHB.
findings: []
- id: PMID:28330616
title: Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.
findings: []
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings: []
- id: PMID:29128334
title: A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration
Reveals New Mechanisms of Redox Homeostasis and NF-ÎșB Signaling.
findings: []
- id: PMID:29924966
title: A Proteomic Variant Approach (ProVarA) for Personalized Medicine of Inherited
and Somatic Disease.
findings: []
- id: PMID:30030361
title: Assembly of mammalian oxidative phosphorylation complexes I-V and supercomplexes.
findings:
- statement: >-
Review of OXPHOS complex assembly. Complex II (SDH) comprises SDHA, SDHB,
SDHC, SDHD.
Assembly involves FAD insertion into SDHA by SDHAF2, followed by SDHA-SDHB
dimerization
and insertion into the membrane via SDHC-SDHD.
- id: PMID:31324722
title: Inhibition of calpain 1 restores plasma membrane stability to pharmacologically
rescued Phe508del-CFTR variant.
findings: []
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
- id: PMID:34800366
title: Quantitative high-confidence human mitochondrial proteome and its dynamics
in cellular context.
findings: []
- id: PMID:35156780
title: CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput
screening system.
findings: []
- id: PMID:37098072
title: Structure of the human respiratory complex II.
findings:
- statement: >-
Cryo-EM structure of human Complex II at 2.86A resolution showing all four
subunits
(SDHA, SDHB, SDHC, SDHD) with FAD, three Fe-S clusters, heme b, and ubiquinone.
SDHA contains four subdomains: FAD-binding, capping, helical, and C-terminal
domains.
The active site for succinate-fumarate interconversion is at the interface
of the
FAD-binding and capping domains. Electron transfer pathway from FAD through
Fe-S
clusters to ubiquinone is proposed.
- id: PMID:7550341
title: Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial
respiratory chain deficiency.
findings:
- statement: >-
First identification of a nuclear gene mutation causing mitochondrial respiratory
chain
deficiency. Homozygous Arg554Trp mutation in SDHA causes Leigh syndrome
with complex II
deficiency in two siblings born to consanguineous parents.
supporting_text: >-
We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit
gene of the
succinate dehydrogenase (SDH) in two siblings with complex II deficiency
presenting as
Leigh syndrome. Both patients were homozygous for an Arg554Trp substitution
in the Fp
subunit. Their parents (first cousins) were heterozygous for the mutation
that occurred
in a conserved domain of the protein and was absent from 120 controls.
reference_section_type: ABSTRACT
full_text_unavailable: true
- statement: >-
The deleterious effect of the Arg554Trp mutation on SDH catalytic activity
was
demonstrated in a yeast complementation assay using an SDH-deficient strain
transformed with mutant Fp cDNA.
supporting_text: >-
The deleterious effect of the Arg to Trp substitution on the catalytic activity
of SDH
was observed in a SDH- yeast strain transformed with mutant Fp cDNA.
reference_section_type: ABSTRACT
full_text_unavailable: true
- statement: >-
The Fp subunit gene is duplicated in the human genome at chromosomes 3q29
and 5p15,
with only the chromosome 5 copy expressed.
supporting_text: >-
The Fp subunit gene is duplicated in the human genome (3q29; 5p15), with
only the gene
on chromosome 5 expressed in human-hamster somatic cell hybrids. This is
the first
report of a nuclear gene mutation causing a mitochondrial respiratory chain
deficiency
in humans.
reference_section_type: ABSTRACT
full_text_unavailable: true
- id: Reactome:R-HSA-70994
title: SDH complex dehydrogenates succinate
findings: []
- id: Reactome:R-HSA-71403
title: Citric acid cycle (TCA cycle)
findings: []
- id: Reactome:R-HSA-9854672
title: FAD attaches to SDHA
findings: []
- id: Reactome:R-HSA-9854961
title: SDHAF4 binds to FAD-SDHA
findings: []
- id: Reactome:R-HSA-9855212
title: SDHA binds to SDHB
findings: []
- id: Reactome:R-HSA-9855252
title: SDHA:SDHB binds to SDHC:SDHD
findings: []
- id: file:human/SDHA/SDHA-deep-research-falcon.md
title: Deep research review of SDHA gene function (Falcon provider)
findings:
- statement: >-
SDHA encodes the covalently flavinylated FAD-containing flavoprotein subunit
of
mitochondrial complex II. Its catalytic role in succinate oxidation and
electron
transfer to ubiquinone is conserved. SDHx genes including SDHA contribute
to
paraganglioma/pheochromocytoma (PPGL) genetics.
supporting_text: >-
Complex II (succinate dehydrogenase, SDH) catalyzes the oxidation of succinate
to fumarate, coupling two-electron transfer via FAD and iron-sulfur centers
to
reduce ubiquinone to ubiquinol in the inner mitochondrial membrane
core_functions:
- molecular_function:
id: GO:0000104
label: succinate dehydrogenase activity
contributes_to_molecular_function:
id: GO:0008177
label: succinate dehydrogenase (quinone) activity
directly_involved_in:
- id: GO:0006121
label: mitochondrial electron transport, succinate to ubiquinone
- id: GO:0006099
label: tricarboxylic acid cycle
locations:
- id: GO:0005759
label: mitochondrial matrix
in_complex:
id: GO:0045273
label: respiratory chain complex II (succinate dehydrogenase)
description: >-
SDHA is the catalytic flavoprotein subunit of succinate dehydrogenase (Complex
II).
It contains a covalently bound FAD cofactor at His99 and catalyzes the oxidation
of
succinate to fumarate as part of the TCA cycle (GO:0006099). The electrons are
transferred
via FAD through SDHB iron-sulfur centers to ubiquinone, coupling the TCA cycle
to the
electron transport chain (GO:0006121). SDHA enables succinate dehydrogenase
activity (GO:0000104)
and contributes to the overall succinate dehydrogenase quinone activity (GO:0008177)
of
the Complex II heterotetramer. The complex resides in the inner mitochondrial
membrane
with SDHA facing the matrix.
supported_by:
- reference_id: PMID:37098072
supporting_text: >-
Human complex II is a key protein complex that links two essential energy-producing
processes: the tricarboxylic acid cycle and oxidative phosphorylation
- reference_id: PMID:7550341
supporting_text: >-
We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit
gene
of the succinate dehydrogenase (SDH) in two siblings with complex II deficiency